Sandbox coretopics: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
(Blanked the page)
Line 1: Line 1:
__NOTOC__


{| class="wikitable"
! Specialty
! Topic
! Section
! Figure
! Table
|-
| Cardiology||[[Electrocardiography]]||Approach||QRS axis||–
|-
| Cardiology||[[Electrocardiography]]||Left axis deviation (LAD)||–||–
|-
| Cardiology||[[Electrocardiography]]||Right axis deviation (RAD)||–||Bunble branch blocks
|-
| Cardiology||[[Electrocardiography]]||Prolonged QT interval||ECG P Wave Criteria||–
|-
| Cardiology||[[Electrocardiography]]||Left ventricular hypertrophy (LVH)||–||–
|-
| Cardiology||[[Electrocardiography]]||Right ventricular hypertrophy (RVH)||–||–
|-
| Cardiology||[[Electrocardiography]]||Ddx of dominant R wave in V1 or V2||–||–
|-
| Cardiology||[[Electrocardiography]]||Poor R wave progression (PRWP)||–||–
|-
| Cardiology||[[Electrocardiography]]||Pathologic Q waves||–||–
|-
| Cardiology||[[Electrocardiography]]||ST elevation (STE)||–||–
|-
| Cardiology||[[Electrocardiography]]||ST depression (STD)||–||–
|-
| Cardiology||[[Electrocardiography]]||T wave inversion (TWI)||–||–
|-
| Cardiology||[[Electrocardiography]]||Low voltage||–||–
|-
| Cardiology||[[Chest pain]]||Causes of Chest Pain||–||Causes of Chest Pain
|-
| Cardiology||[[Chest pain]]||Initial approach||–||–
|-
| Cardiology||[[Noninvasive evaluation of cad]]||Noninvasive Evaluation of CAD||–||Noninvasive Evaluation of CAD
|-
| Cardiology||[[Noninvasive evaluation of cad]]||Stress testing||–||–
|-
| Cardiology||[[Noninvasive evaluation of cad]]||Test results||–||–
|-
| Cardiology||[[Noninvasive evaluation of cad]]||High-risk test results||–||–
|-
| Cardiology||[[Noninvasive evaluation of cad]]||Myocardial viability||–||–
|-
| Cardiology||[[Noninvasive evaluation of cad]]||CT & MR coronary angio||–||–
|-
| Cardiology||[[Noninvasive evaluation of cad]]||Coronary artery calcium score||–||–
|-
| Cardiology||[[Coronary angiography and revascularization]]||Indications for coronary angiography in stable CAD or asx Pts||–||–
|-
| Cardiology||[[Coronary angiography and revascularization]]||Precath checklist||–||–
|-
| Cardiology||[[Coronary angiography and revascularization]]||Coronary revascularization in stable CAD||–||–
|-
| Cardiology||[[Coronary angiography and revascularization]]||PCI||–||–
|-
| Cardiology||[[Coronary angiography and revascularization]]||Post-PCI complications||–||–
|-
| Cardiology||[[Acute coronary syndromes]]||Ddx (causes of myocardial ischemia/infarction other than atherosclerotic plaque rupture)||–||Spectrum of Acute Coronary Syndromes
|-
| Cardiology||[[Acute coronary syndromes]]||Clinical manifestations||–||–
|-
| Cardiology||[[Acute coronary syndromes]]||Physical exam||–||–
|-
| Cardiology||[[Acute coronary syndromes]]||Diagnostic studies||–||Localization of MI
|-
| Cardiology||[[Acute coronary syndromes]]||Prinzmetal’s (variant) angina||–||–
|-
| Cardiology||[[Acute coronary syndromes]]||Approach to triage||–||Likelihood of ACS
|-
| Cardiology||[[Acute coronary syndromes]]||Coronary angiography||–||–
|-
| Cardiology||[[Ua/nstemi]]||Approach to UA/NSTEMI||Approach to UA/NSTEMI||–
|-
| Cardiology||[[Ua/nstemi]]||TIMI Risk Score for UA/NSTEMI||–||TIMI Risk Score for UA/NSTEMI
|-
| Cardiology||[[Ua/nstemi]]||Anti-Ischemic and Antiplatelet Therapy for UA/NSTEMI||–||Anti-Ischemic and Antiplatelet Therapy for UA/NSTEMI
|-
| Cardiology||[[Ua/nstemi]]||Anticoagulant Therapy for UA/NSTEMI||–||Anticoagulant Therapy for UA/NSTEMI
|-
| Cardiology||[[Stemi]]||Requisite STE (at J point)||–||–
|-
| Cardiology||[[Stemi]]||Reperfusion (“time is muscle”)||–||Fibrinolysis vs Hospital Transfer for Primary PCI
|-
| Cardiology||[[Stemi]]||Primary PCI||–||–
|-
| Cardiology||[[Stemi]]||Fibrinolysis||–||Contraindications to Fibrinolysis
|-
| Cardiology||[[Stemi]]||Non-primary PCI||–||–
|-
| Cardiology||[[Stemi]]||Antiplatelet Therapy for STEMI||–||Antiplatelet Therapy for STEMI
|-
| Cardiology||[[Stemi]]||Anticoagulant Therapy for STEMI||–||Anticoagulant Therapy for STEMI
|-
| Cardiology||[[Stemi]]||Immediate Adjunctive Therapy for STEMI||–||Immediate Adjunctive Therapy for STEMI
|-
| Cardiology||[[Stemi]]||LV failure||–||–
|-
| Cardiology||[[Stemi]]||Inferior MI complications||–||–
|-
| Cardiology||[[Stemi]]||Mechanical complications||–||–
|-
| Cardiology||[[Stemi]]||Post-MI Arrhythmias||–||Other Post-MI Complications
|-
| Cardiology||[[Stemi]]||Prognosis based on Killip Class||–||Prognosis based on Killip Class
|-
| Cardiology||[[Stemi]]||Prognosis based on Forrester Class||–||Prognosis based on Forrester Class
|-
| Cardiology||[[Pre-discharge checklist and long-term post-acs management]]||Risk stratification||–||–
|-
| Cardiology||[[Pre-discharge checklist and long-term post-acs management]]||Medications (barring contraindications)||–||–
|-
| Cardiology||[[Pre-discharge checklist and long-term post-acs management]]||ICD||–||–
|-
| Cardiology||[[Pre-discharge checklist and long-term post-acs management]]||Risk factors and lifestyle modifications||–||–
|-
| Cardiology||[[Pa catheter and tailored therapy]]||Rationale||PA Catheter Waveforms||–
|-
| Cardiology||[[Pa catheter and tailored therapy]]||Indications||–||–
|-
| Cardiology||[[Pa catheter and tailored therapy]]||Efficacy concerns||–||–
|-
| Cardiology||[[Pa catheter and tailored therapy]]||Placement||–||–
|-
| Cardiology||[[Pa catheter and tailored therapy]]||Complications||–||–
|-
| Cardiology||[[Pa catheter and tailored therapy]]||Intracardiac pressures||–||–
|-
| Cardiology||[[Pa catheter and tailored therapy]]||Cardiac output||–||–
|-
| Cardiology||[[Pa catheter and tailored therapy]]||Tailored therapy in cardiogenic shock||–||Hemodynamic Profiles of Various Forms of Shock
|-
| Cardiology||[[Heart failure]]||Definitions||–||–
|-
| Cardiology||[[Heart failure]]||History||–||–
|-
| Cardiology||[[Heart failure]]||Functional classification (New York Heart Association class)||–||–
|-
| Cardiology||[[Heart failure]]||Physical exam (“2-minute” hemodynamic profile)||–||–
|-
| Cardiology||[[Heart failure]]||Evaluation for the presence of heart failure||–||–
|-
| Cardiology||[[Heart failure]]||Evaluation of the causes of heart failure||Approach to left-sided heart failure||–
|-
| Cardiology||[[Heart failure]]||Precipitants of acute heart failure||–||–
|-
| Cardiology||[[Heart failure]]||Treatment of acute decompensated heart failure||–||Treatment of acute decompensated heart failure
|-
| Cardiology||[[Heart failure]]||Treatment of advanced heart failure||–||Recommended Chronic Therapy by HF Stage
|-
| Cardiology||[[Heart failure]]||Heart failure with reduced EF (HFrEF)||–||Treatment of HFrEF
|-
| Cardiology||[[Heart failure]]||Heart failure with preserved EF (HFpEF)||–||–
|-
| Cardiology||[[Dilated cardiomyopathy]]||Definition and epidemiology||–||–
|-
| Cardiology||[[Dilated cardiomyopathy]]||Etiologies||–||–
|-
| Cardiology||[[Dilated cardiomyopathy]]||Clinical manifestations||–||–
|-
| Cardiology||[[Dilated cardiomyopathy]]||Diagnostic studies and workup||–||–
|-
| Cardiology||[[Dilated cardiomyopathy]]||Treatment||–||–
|-
| Cardiology||[[Hypertrophic cardiomyopathy]]||Definition and epidemiology||–||–
|-
| Cardiology||[[Hypertrophic cardiomyopathy]]||Pathology||–||–
|-
| Cardiology||[[Hypertrophic cardiomyopathy]]||Pathophysiology||–||–
|-
| Cardiology||[[Hypertrophic cardiomyopathy]]||Clinical manifestations||–||–
|-
| Cardiology||[[Hypertrophic cardiomyopathy]]||Physical exam||–||–
|-
| Cardiology||[[Hypertrophic cardiomyopathy]]||Diagnostic studies||–||–
|-
| Cardiology||[[Hypertrophic cardiomyopathy]]||Treatment||–||–
|-
| Cardiology||[[Restrictive cardiomyopathy]]||Definition||–||–
|-
| Cardiology||[[Restrictive cardiomyopathy]]||Etiology||–||–
|-
| Cardiology||[[Restrictive cardiomyopathy]]||Pathology & pathophysiology||–||–
|-
| Cardiology||[[Restrictive cardiomyopathy]]||Clinical manifestations||–||–
|-
| Cardiology||[[Restrictive cardiomyopathy]]||Physical exam||–||–
|-
| Cardiology||[[Restrictive cardiomyopathy]]||Diagnostic studies||–||–
|-
| Cardiology||[[Restrictive cardiomyopathy]]||Treatment||–||–
|-
| Cardiology||[[Aortic stenosis]]||Etiology||–||–
|-
| Cardiology||[[Aortic stenosis]]||Clinical manifestations||–||–
|-
| Cardiology||[[Aortic stenosis]]||Physical exam||Hemodynamics of Aortic Stenosis||–
|-
| Cardiology||[[Aortic stenosis]]||Diagnostic studies||–||Classification of Aortic Stenosis
|-
| Cardiology||[[Aortic stenosis]]||Treatment||–||–
|-
| Cardiology||[[Aortic insufficiency]]||Etiology||–||–
|-
| Cardiology||[[Aortic insufficiency]]||Clinical manifestations||–||Classic Eponymous Signs in Chronic Aortic Insufficiency
|-
| Cardiology||[[Aortic insufficiency]]||Physical exam||Hemodynamics of Aortic Insufficiency||–
|-
| Cardiology||[[Aortic insufficiency]]||Diagnostic studies||–||–
|-
| Cardiology||[[Aortic insufficiency]]||Treatment||–||–
|-
| Cardiology||[[Mitral regurgitation]]||Etiology||–||–
|-
| Cardiology||[[Mitral regurgitation]]||Clinical manifestations||–||–
|-
| Cardiology||[[Mitral regurgitation]]||Physical exam||Hemodynamics of Mitral Regurgitation||–
|-
| Cardiology||[[Mitral regurgitation]]||Diagnostic studies||–||Classification of Mitral Regurgitation
|-
| Cardiology||[[Mitral regurgitation]]||Treatment||–||–
|-
| Cardiology||[[Mitral stenosis]]||Etiology||–||–
|-
| Cardiology||[[Mitral stenosis]]||Clinical manifestations||–||–
|-
| Cardiology||[[Mitral stenosis]]||Physical exam||Hemodynamics of Mitral Stenosis||–
|-
| Cardiology||[[Mitral stenosis]]||Diagnostic studies||–||Classification of Mitral Stenosis
|-
| Cardiology||[[Mitral stenosis]]||Treatment||–||–
|-
| Cardiology||[[Mitral valve prolapse]]||Definition and etiology||–||–
|-
| Cardiology||[[Mitral valve prolapse]]||Clinical manifestations||–||–
|-
| Cardiology||[[Mitral valve prolapse]]||Physical exam||–||–
|-
| Cardiology||[[Mitral valve prolapse]]||Treatment||–||–
|-
| Cardiology||[[Tricuspid regurgitation]]||Tricuspid regurgitation||–||–
|-
| Cardiology||[[Prosthetic heart valves]]||Mechanical||Superior View of Heart Valves||–
|-
| Cardiology||[[Prosthetic heart valves]]||Bioprosthetic||–||–
|-
| Cardiology||[[Prosthetic heart valves]]||Physical exam||–||–
|-
| Cardiology||[[Prosthetic heart valves]]||Anticoagulation & antiplatelet therapy||–||Periprocedural Bridging of Anticoagulation in Pts with MV
|-
| Cardiology||[[Prosthetic heart valves]]||Correction of overanticoagulation||–||–
|-
| Cardiology||[[Prosthetic heart valves]]||Endocarditis prophylaxis||–||–
|-
| Cardiology||[[Prosthetic heart valves]]||Complications||–||–
|-
| Cardiology||[[Pericardial disease]]||Anatomy||–||–
|-
| Cardiology||[[Pericardial disease]]||Disease states||–||–
|-
| Cardiology||[[Pericarditis and pericardial effusion]]||Etiology||–||Etiologies of Acute Pericarditis
|-
| Cardiology||[[Pericarditis and pericardial effusion]]||Clinical manifestations||–||–
|-
| Cardiology||[[Pericarditis and pericardial effusion]]||Physical exam||–||–
|-
| Cardiology||[[Pericarditis and pericardial effusion]]||Diagnostic studies||–||–
|-
| Cardiology||[[Pericarditis and pericardial effusion]]||Workup for effusion||–||–
|-
| Cardiology||[[Pericarditis and pericardial effusion]]||Treatment of pericarditis||–||–
|-
| Cardiology||[[Pericardial tamponade]]||Etiology||–||–
|-
| Cardiology||[[Pericardial tamponade]]||Pathophysiology||–||–
|-
| Cardiology||[[Pericardial tamponade]]||Clinical manifestations||–||–
|-
| Cardiology||[[Pericardial tamponade]]||Physical exam||–||–
|-
| Cardiology||[[Pericardial tamponade]]||Diagnostic studies||–||–
|-
| Cardiology||[[Pericardial tamponade]]||Treatment||–||–
|-
| Cardiology||[[Constrictive pericarditis]]||Etiology||–||Constrictive Pericarditis vs Restrictive Cardiomyopathy
|-
| Cardiology||[[Constrictive pericarditis]]||Pathophysiology||–||–
|-
| Cardiology||[[Constrictive pericarditis]]||Clinical manifestations||–||–
|-
| Cardiology||[[Constrictive pericarditis]]||Physical exam||–||–
|-
| Cardiology||[[Constrictive pericarditis]]||Diagnostic studies||–||–
|-
| Cardiology||[[Constrictive pericarditis]]||Treatment||–||–
|-
| Cardiology||[[Hypertension]]||Classification||–||JNC VII Classification of Hypertension
|-
| Cardiology||[[Hypertension]]||Epidemiology||–||–
|-
| Cardiology||[[Hypertension]]||Etiologies||–||Secondary Causes of Hypertension
|-
| Cardiology||[[Hypertension]]||Standard workup||–||–
|-
| Cardiology||[[Hypertension]]||Complications of HTN||–||–
|-
| Cardiology||[[Hypertension]]||Treatment||–||–
|-
| Cardiology||[[Hypertensive crises]]||Definitions||–||–
|-
| Cardiology||[[Hypertensive crises]]||Precipitants||–||–
|-
| Cardiology||[[Hypertensive crises]]||Treatment||–||Drugs for Hypertensive Crises
|-
| Cardiology||[[Aortic aneurysms]]||Definitions||–||–
|-
| Cardiology||[[Aortic aneurysms]]||Epidemiology||–||–
|-
| Cardiology||[[Aortic aneurysms]]||Pathophysiology||–||–
|-
| Cardiology||[[Aortic aneurysms]]||Screening||–||–
|-
| Cardiology||[[Aortic aneurysms]]||Diagnostic studies||–||–
|-
| Cardiology||[[Aortic aneurysms]]||Treatment||–||–
|-
| Cardiology||[[Acute aortic syndromes]]||Definitions||–||–
|-
| Cardiology||[[Acute aortic syndromes]]||Classification||–||–
|-
| Cardiology||[[Acute aortic syndromes]]||Risk factors||–||–
|-
| Cardiology||[[Acute aortic syndromes]]||Clinical manifestations||–||Clinical Manifestations and Physical Exam of Acute Aortic Syndromes
|-
| Cardiology||[[Acute aortic syndromes]]||Diagnostic studies||–||–
|-
| Cardiology||[[Acute aortic syndromes]]||Treatment||–||–
|-
| Cardiology||[[Acute aortic syndromes]]||Complications||–||–
|-
| Cardiology||[[Bradycardias, av block, and av dissociation]]||Sinus bradycardia (SB) ||–||–
|-
| Cardiology||[[Bradycardias, av block, and av dissociation]]||Sick sinus syndrome (SSS)||–||–
|-
| Cardiology||[[Bradycardias, av block, and av dissociation]]||AV Block||–||Classification of AV Block
|-
| Cardiology||[[Bradycardias, av block, and av dissociation]]||AV Dissociation||–||–
|-
| Cardiology||[[Bradycardias, av block, and av dissociation]]||Temporary pacing wires||–||–
|-
| Cardiology||[[Supraventricular tachycardias]]||Approach||–||Approach to SVT
|-
| Cardiology||[[Supraventricular tachycardias]]||Etiology||–||Common Etiologies of SVT
|-
| Cardiology||[[Supraventricular tachycardias]]||Diagnosis||–||Diagnosis of SVT
|-
| Cardiology||[[Supraventricular tachycardias]]||Treatment||–||Treatment of SVT
|-
| Cardiology||[[Accessory pathways (wolff-parkinson-white)]]||Definitions||Delta wave of WPW Syndrome||–
|-
| Cardiology||[[Accessory pathways (wolff-parkinson-white)]]||Classic tachycardias of WPW||–||–
|-
| Cardiology||[[Accessory pathways (wolff-parkinson-white)]]||Treatment||–||–
|-
| Cardiology||[[Wide-complex tachycardias]]||Etiology||–||–
|-
| Cardiology||[[Wide-complex tachycardias]]||Monomorphic ventricular tachycardia (MMVT)||Epsilon wave in ARVD||–
|-
| Cardiology||[[Wide-complex tachycardias]]||Polymorphic ventricular tachycardia (PMVT)||ECG of Brugada Syndrome||–
|-
| Cardiology||[[Wide-complex tachycardias]]||Diagnostic clues that favor VT (assume until proven o/w)||–||–
|-
| Cardiology||[[Wide-complex tachycardias]]||Long-term management||–||–
|-
| Cardiology||[[Atrial fibrillation]]||Classification||–||–
|-
| Cardiology||[[Atrial fibrillation]]||Epidemiology and etiologies||–||–
|-
| Cardiology||[[Atrial fibrillation]]||Evaluation||–||Approach to Acute AF
|-
| Cardiology||[[Atrial fibrillation]]||Strategies for recurrent AF||–||Rate Control for AF
|-
| Cardiology||[[Atrial fibrillation]]||Cardioversion||–||Antiarrhythmic Drugs for AF
|-
| Cardiology||[[Atrial fibrillation]]||Nonpharmacologic therapy||–||–
|-
| Cardiology||[[Atrial fibrillation]]||Oral anticoagulation||–||Novel Oral Anticoagulants for Nonvalvular AF
|-
| Cardiology||[[Syncope]]||Definition||–||–
|-
| Cardiology||[[Syncope]]||Etiologies||–||–
|-
| Cardiology||[[Syncope]]||Workup||Approach to Syncope||–
|-
| Cardiology||[[Syncope]]||Other diagnostic studies||–||–
|-
| Cardiology||[[Syncope]]||High-risk features||–||–
|-
| Cardiology||[[Syncope]]||Treatment||–||–
|-
| Cardiology||[[Syncope]]||Prognosis||–||–
|-
| Cardiology||[[Intracardiac devices]]||Pacemaker Code||–||Pacemaker Code
|-
| Cardiology||[[Intracardiac devices]]||Common Pacing Modes||–||Common Pacing Modes
|-
| Cardiology||[[Intracardiac devices]]||Indications for Permanent Pacing||–||Indications for Permanent Pacing
|-
| Cardiology||[[Intracardiac devices]]||Permanent Pacemaker Complications||–||Permanent Pacemaker Complications
|-
| Cardiology||[[Intracardiac devices]]||Cardiac resynch therapy (CRT)/Biventricular (BiV) pacing||–||–
|-
| Cardiology||[[Intracardiac devices]]||Implantable cardiac defibrillator (ICD)||–||–
|-
| Cardiology||[[Intracardiac devices]]||Device infection||–||–
|-
| Cardiology||[[Cardiac risk assessment for noncardiac surgery]]||Clinical Assessment||–||Clinical Assessment
|-
| Cardiology||[[Cardiac risk assessment for noncardiac surgery]]||Surgery-Specific Risk||–||Surgery-Specific Risk
|-
| Cardiology||[[Cardiac risk assessment for noncardiac surgery]]||Functional Capacity||–||Functional Capacity
|-
| Cardiology||[[Cardiac risk assessment for noncardiac surgery]]||Noninvasive Testing Result||–||Noninvasive Testing Result
|-
| Cardiology||[[Cardiac risk assessment for noncardiac surgery]]||Preoperative evaluation||ACC/AHA approach to preoperative cardiovascular evaluation for noncardiac surgery||–
|-
| Cardiology||[[Cardiac risk assessment for noncardiac surgery]]||Preoperative testing and assessment||–||–
|-
| Cardiology||[[Cardiac risk assessment for noncardiac surgery]]||Pre- & perioperative management||–||–
|-
| Cardiology||[[Cardiac risk assessment for noncardiac surgery]]||Perioperative β-blocker||–||–
|-
| Cardiology||[[Cardiac risk assessment for noncardiac surgery]]||Postoperative monitoring||–||–
|-
| Cardiology||[[Peripheral artery disease]]||Clinical features||–||–
|-
| Cardiology||[[Peripheral artery disease]]||Diagnosis||–||–
|-
| Cardiology||[[Peripheral artery disease]]||Treatment||–||–
|-
| Cardiology||[[Peripheral artery disease]]||Acute limb ischemia (ALI)||–||–
|-
| Pulmonary||[[Dyspnea]]||Etiologies||–||Etiologies of Dyspnea
|-
| Pulmonary||[[Dyspnea]]||Evaluation||–||–
|-
| Pulmonary||[[Pulmonary function tests]]||Approach to abnormal PFTs||Approach to abnormal PFTs||–
|-
| Pulmonary||[[Asthma]]||Definition and epidemiology||–||–
|-
| Pulmonary||[[Asthma]]||Clinical manifestations||–||–
|-
| Pulmonary||[[Asthma]]||Physical examination||–||–
|-
| Pulmonary||[[Asthma]]||Diagnostic studies||–||–
|-
| Pulmonary||[[Asthma]]||Ddx||–||–
|-
| Pulmonary||[[Asthma]]||“Asthma plus” syndromes||–||–
|-
| Pulmonary||[[Asthma]]||“Reliever” medications||–||–
|-
| Pulmonary||[[Asthma]]||“Controller” meds||–||–
|-
| Pulmonary||[[Asthma]]||Other||–||–
|-
| Pulmonary||[[Asthma]]||Principles of treatment||–||Asthma Stepwise Therapy
|-
| Pulmonary||[[Asthma exacerbation resident survival guide|Asthma exacerbation]]||Evaluation||–||Severity of Asthma Exacerbation
|-
| Pulmonary||[[Asthma exacerbation resident survival guide|Asthma exacerbation]]||Initial treatment ||Disposition of patients after initial treatment of asthma exacerbation||–
|-
| Pulmonary||[[Asthma exacerbation resident survival guide|Asthma exacerbation]]||ICU-level care||–||–
|-
| Pulmonary||[[Anaphylaxis]]||Definition and pathophysiology||–||–
|-
| Pulmonary||[[Anaphylaxis]]||Diagnosis||–||–
|-
| Pulmonary||[[Anaphylaxis]]||Treatment||–||–
|-
| Pulmonary||[[Anaphylaxis]]||Disposition||–||–
|-
| Pulmonary||[[Chronic obstructive pulmonary disease]]||Definition and epidemiology||–||Emphysema vs Chronic Bronchitis
|-
| Pulmonary||[[Chronic obstructive pulmonary disease]]||Pathogenesis||–||–
|-
| Pulmonary||[[Chronic obstructive pulmonary disease]]||Clinical manifestations||–||–
|-
| Pulmonary||[[Chronic obstructive pulmonary disease]]||Diagnostic studies||–||–
|-
| Pulmonary||[[Chronic obstructive pulmonary disease]]||Chronic treatment||–||–
|-
| Pulmonary||[[Chronic obstructive pulmonary disease]]||Staging and prognosis||–||COPD Staging and Recommended Therapies by GOLD Criteria
|-
| Pulmonary||[[Chronic obstructive pulmonary disease]]||Exacerbation||–||COPD Exacerbation Treatment
|-
| Pulmonary||[[Hemoptysis]]||Definition and pathophysiology||–||–
|-
| Pulmonary||[[Hemoptysis]]||Etiologies||–||Etiologies of Hemoptysis
|-
| Pulmonary||[[Hemoptysis]]||Diagnostic workup||–||–
|-
| Pulmonary||[[Hemoptysis]]||Treatment||–||–
|-
| Pulmonary||[[Bronchiectasis]]||Definition and epidemiology||–||–
|-
| Pulmonary||[[Bronchiectasis]]||Initial workup||–||Etiologies of Bronchiectasis
|-
| Pulmonary||[[Bronchiectasis]]||Treatment||–||–
|-
| Pulmonary||[[Solitary pulmonary nodule]]||Principles||–||Etiologies of SPN
|-
| Pulmonary||[[Solitary pulmonary nodule]]||Initial evaluation||–||–
|-
| Pulmonary||[[Solitary pulmonary nodule]]||Diagnostic studies||–||–
|-
| Pulmonary||[[Solitary pulmonary nodule]]||Management||–||–
|-
| Pulmonary||[[Obstructive sleep apnea]]||Definition and pathophysiology||–||–
|-
| Pulmonary||[[Obstructive sleep apnea]]||Clinical manifestations||–||–
|-
| Pulmonary||[[Obstructive sleep apnea]]||Diagnosis and treatment||–||–
|-
| Pulmonary||[[Interstitial lung disease]]||Workup of ILD||–||–
|-
| Pulmonary||[[Interstitial lung disease]]||Etiologies of ILD||–||Clinical Manifestations of Sarcoidosis
|-
| Pulmonary||[[Interstitial lung disease]]||Idiopathic Interstitial Pneumonias||–||Classification of Idiopathic Interstitial Pneumonia
|-
| Pulmonary||[[Pleural effusion]]||Pathophysiology||–||–
|-
| Pulmonary||[[Pleural effusion]]||Transudates||–||–
|-
| Pulmonary||[[Pleural effusion]]||Exudates||–||–
|-
| Pulmonary||[[Pleural effusion]]||Diagnostic studies||–||Characteristics of Pleural Fluid
|-
| Pulmonary||[[Pleural effusion]]||Treatment||–||–
|-
| Pulmonary||[[Venous thromboembolism]]||Definitions||–||–
|-
| Pulmonary||[[Venous thromboembolism]]||Risk factors||–||Thromboprophylaxis
|-
| Pulmonary||[[Venous thromboembolism]]||Clinical manifestations—DVT||–||Simplified Wells Pretest Probability Scoring for DVT
|-
| Pulmonary||[[Venous thromboembolism]]||Diagnostic studies—DVT||Approach to Suspected DVT||–
|-
| Pulmonary||[[Venous thromboembolism]]||Clinical manifestations—PE||–||Simplified Wells Pretest Probability Scoring for PE
|-
| Pulmonary||[[Venous thromboembolism]]||Diagnostic studies—PE ||Approach to Suspected PE using CTA||–
|-
| Pulmonary||[[Venous thromboembolism]]||Workup for idiopathic VTE||–||–
|-
| Pulmonary||[[Venous thromboembolism]]||Risk stratification for Pts with PE||–||–
|-
| Pulmonary||[[Venous thromboembolism]]||Treatment of VTE||–||–
|-
| Pulmonary||[[Venous thromboembolism]]||Complications & prognosis||–||–
|-
| Pulmonary||[[Pulmonary hypertension]]||Pathobiology||–||Etiologies of Pulmonary Hypertension
|-
| Pulmonary||[[Pulmonary hypertension]]||Clinical manifestations||–||–
|-
| Pulmonary||[[Pulmonary hypertension]]||Physical exam||–||–
|-
| Pulmonary||[[Pulmonary hypertension]]||Diagnostic studies & workup||–||–
|-
| Pulmonary||[[Pulmonary hypertension]]||Treatment||Treatment of PAH||–
|-
| Pulmonary||[[Pulmonary hypertension]]||Treatment||–||Vasoactive Agents for PAH
|-
| Pulmonary||[[Pulmonary hypertension]]||Management of ICU patient||–||–
|-
| Pulmonary||[[Pulmonary hypertension]]||Prognosis||–||–
|-
| Pulmonary||[[Respiratory failure]]||Hypoxia||Workup of acute hypoxemia||–
|-
| Pulmonary||[[Respiratory failure]]||Chemical Causes of Cellular Hypoxia||–||Chemical Causes of Cellular Hypoxia
|-
| Pulmonary||[[Respiratory failure]]||Hypercapnia||–||Etiologies of Hypercapnia
|-
| Pulmonary||[[Mechanical ventilation]]||Indications||–||–
|-
| Pulmonary||[[Mechanical ventilation]]||Choosing settings||–||–
|-
| Pulmonary||[[Mechanical ventilation]]||Pick Ventilator Mode||–||Pick Ventilator Mode
|-
| Pulmonary||[[Mechanical ventilation]]||Choose Volume Targeted or Pressure Targeted||–||Choose Volume Targeted or Pressure Targeted
|-
| Pulmonary||[[Mechanical ventilation]]||Set Remaining Variables||–||Set Remaining Variables
|-
| Pulmonary||[[Mechanical ventilation]]||Initial Settings||–||Initial Settings
|-
| Pulmonary||[[Mechanical ventilation]]||Noninvasive CPAP/Ventilation||–||Noninvasive CPAP/Ventilation
|-
| Pulmonary||[[Mechanical ventilation]]||Tailoring the ventilator settings||–||–
|-
| Pulmonary||[[Mechanical ventilation]]||Acute ventilatory deterioration||Approach to acute ventilatory deterioration||–
|-
| Pulmonary||[[Mechanical ventilation]]||Weaning from the ventilator||–||–
|-
| Pulmonary||[[Mechanical ventilation]]||Complications||–||–
|-
| Pulmonary||[[Acute respiratory distress syndrome]]||New “Berlin” definition||–||–
|-
| Pulmonary||[[Acute respiratory distress syndrome]]||Pathophysiology||–||Etiologies of ARDS
|-
| Pulmonary||[[Acute respiratory distress syndrome]]||Treatment||–||Ventilator Strategies by VILI Mechanisms
|-
| Pulmonary||[[Acute respiratory distress syndrome]]||Prognosis||–||–
|-
| Pulmonary||[[Sepsis]]||Definitions||–||Sepsis Definitions
|-
| Pulmonary||[[Sepsis]]||Fluids & vasoactive drugs||–||–
|-
| Pulmonary||[[Sepsis]]||Antibiotics||–||–
|-
| Pulmonary||[[Sepsis]]||Steroids||–||–
|-
| Pulmonary||[[Sepsis]]||Activated protein C||–||–
|-
| Pulmonary||[[Sepsis]]||Intensive glycemic control||–||–
|-
| Gastroenterology||[[Dysphagia]]||Definitions||Etiologies of and approach to dysphagia||–
|-
| Gastroenterology||[[Achalasia]]||Achalasia||–||–
|-
| Gastroenterology||[[Other esophageal disorders]]||Other esophageal disorders||–||–
|-
| Gastroenterology||[[Gastroesophageal reflux disease]]||Pathophysiology||–||–
|-
| Gastroenterology||[[Gastroesophageal reflux disease]]||Clinical manifestations||–||–
|-
| Gastroenterology||[[Gastroesophageal reflux disease]]||Diagnosis||–||–
|-
| Gastroenterology||[[Gastroesophageal reflux disease]]||Treatment||–||–
|-
| Gastroenterology||[[Gastroesophageal reflux disease]]||Complications||–||–
|-
| Gastroenterology||[[Dyspepsia]]||Definition||–||–
|-
| Gastroenterology||[[Dyspepsia]]||Etiologies||–||–
|-
| Gastroenterology||[[Dyspepsia]]||Treatment of functional dyspepsia||–||–
|-
| Gastroenterology||[[Peptic ulcer disease]]||Epidemiology & etiologies||–||–
|-
| Gastroenterology||[[Peptic ulcer disease]]||Clinical manifestations||–||–
|-
| Gastroenterology||[[Peptic ulcer disease]]||Diagnostic studies||–||–
|-
| Gastroenterology||[[Peptic ulcer disease]]||Treatment||–||–
|-
| Gastroenterology||[[Peptic ulcer disease]]||Prophylaxis if ASA/NSAID required||–||–
|-
| Gastroenterology||[[Gastrointestinal bleeding]]||Definition||–||–
|-
| Gastroenterology||[[Gastrointestinal bleeding]]||Etiologies of upper GI bleed (UGIB)||–||–
|-
| Gastroenterology||[[Gastrointestinal bleeding]]||Etiologies of lower GI bleed (LGIB)||–||–
|-
| Gastroenterology||[[Gastrointestinal bleeding]]||Clinical manifestations||–||–
|-
| Gastroenterology||[[Gastrointestinal bleeding]]||Initial management||–||–
|-
| Gastroenterology||[[Gastrointestinal bleeding]]||Workup||–||–
|-
| Gastroenterology||[[Gastrointestinal bleeding]]||Diagnostic studies||–||–
|-
| Gastroenterology||[[Gastrointestinal bleeding]]||Treatment of GIB by Etiologies||–||Treatment of GIB by Etiologies
|-
| Gastroenterology||[[Gastrointestinal bleeding]]||Obscure GIB||–||–
|-
| Gastroenterology||[[Acute diarrhea]]||Infectious Etiologies of Acute Diarrhea||–||Infectious Etiologies of Acute Diarrhea
|-
| Gastroenterology||[[Acute diarrhea]]||Evaluation||–||–
|-
| Gastroenterology||[[Acute diarrhea]]||Treatment||–||–
|-
| Gastroenterology||[[Clostridium difficile-associated diarrhea]]||Pathogenesis||–||–
|-
| Gastroenterology||[[Clostridium difficile-associated diarrhea]]||Clinical manifestations||–||–
|-
| Gastroenterology||[[Clostridium difficile-associated diarrhea]]||Diagnosis||–||–
|-
| Gastroenterology||[[Clostridium difficile-associated diarrhea]]||Treatment||–||–
|-
| Gastroenterology||[[Chronic diarrhea]]||Medications||–||–
|-
| Gastroenterology||[[Chronic diarrhea]]||Osmotic||–||–
|-
| Gastroenterology||[[Chronic diarrhea]]||Malabsorption||–||–
|-
| Gastroenterology||[[Chronic diarrhea]]||Inflammatory||–||–
|-
| Gastroenterology||[[Chronic diarrhea]]||Secretory||–||–
|-
| Gastroenterology||[[Chronic diarrhea]]||Motility||–||–
|-
| Gastroenterology||[[Chronic diarrhea]]||Workup of chronic diarrhea||Workup of chronic diarrhea||–
|-
| Gastroenterology||[[Constipation and adynamic ileus]]||Constipation||–||–
|-
| Gastroenterology||[[Constipation and adynamic ileus]]||Acute pseudo-obstruction (adynamic ileus)||–||–
|-
| Gastroenterology||[[Nutrition in hospitalized patients]]||Pathophysiology||–||–
|-
| Gastroenterology||[[Nutrition in hospitalized patients]]||Critical illness||–||–
|-
| Gastroenterology||[[Nutrition in hospitalized patients]]||End-stage liver disease||–||–
|-
| Gastroenterology||[[Nutrition in hospitalized patients]]||Refeeding syndrome||–||–
|-
| Gastroenterology||[[Diverticulosis]]||Definition & pathobiology||–||–
|-
| Gastroenterology||[[Diverticulosis]]||Epidemiology||–||–
|-
| Gastroenterology||[[Diverticulosis]]||Clinical manifestations||–||–
|-
| Gastroenterology||[[Diverticulitis]]||Pathophysiology||–||–
|-
| Gastroenterology||[[Diverticulitis]]||Clinical manifestations||–||–
|-
| Gastroenterology||[[Diverticulitis]]||Diagnostic studies||–||–
|-
| Gastroenterology||[[Diverticulitis]]||Treatment||–||–
|-
| Gastroenterology||[[Diverticulitis]]||Prevention||–||–
|-
| Gastroenterology||[[Diverticular hemorrhage]]||Pathophysiology||–||–
|-
| Gastroenterology||[[Diverticular hemorrhage]]||Clinical manifestations||–||–
|-
| Gastroenterology||[[Diverticular hemorrhage]]||Diagnostic studies||–||–
|-
| Gastroenterology||[[Diverticular hemorrhage]]||Treatment||–||–
|-
| Gastroenterology||[[Inflammatory bowel disease]]||Definition||–||–
|-
| Gastroenterology||[[Inflammatory bowel disease]]||Epidemiology & pathophysiology||–||–
|-
| Gastroenterology||[[Ulcerative colitis]]||Clinical manifestations||–||–
|-
| Gastroenterology||[[Ulcerative colitis]]||Diagnosis||–||–
|-
| Gastroenterology||[[Ulcerative colitis]]||Complications||–||–
|-
| Gastroenterology||[[Ulcerative colitis]]||Prognosis||–||–
|-
| Gastroenterology||[[Crohn's disease]]||Clinical manifestations||–||–
|-
| Gastroenterology||[[Crohn's disease]]||Diagnosis||–||–
|-
| Gastroenterology||[[Crohn's disease]]||Complications||–||–
|-
| Gastroenterology||[[Crohn's disease]]||Prognosis||–||–
|-
| Gastroenterology||[[Management of inflammatory bowel disease]]||Initial evaluation||–||IBD Induction of Remission
|-
| Gastroenterology||[[Management of inflammatory bowel disease]]||Goals of treatment||–||IBD Maintenance of Remission
|-
| Gastroenterology||[[Management of inflammatory bowel disease]]||Complications of therapy||–||–
|-
| Gastroenterology||[[Management of inflammatory bowel disease]]||Cancer screening||–||–
|-
| Gastroenterology||[[Acute mesenteric ischemia]]||Etiologies||–||–
|-
| Gastroenterology||[[Acute mesenteric ischemia]]||Clinical manifestations||–||–
|-
| Gastroenterology||[[Acute mesenteric ischemia]]||Physical exam||–||–
|-
| Gastroenterology||[[Acute mesenteric ischemia]]||Diagnostic studies||–||–
|-
| Gastroenterology||[[Acute mesenteric ischemia]]||Treatment||–||–
|-
| Gastroenterology||[[Acute mesenteric ischemia]]||Prognosis||–||–
|-
| Gastroenterology||[[Ischemic colitis]]||Definition & pathophysiology||–||–
|-
| Gastroenterology||[[Ischemic colitis]]||Clinical manifestations, diagnosis, & treatment||–||–
|-
| Gastroenterology||[[Pancreatitis]]||Pathogenesis||–||–
|-
| Gastroenterology||[[Pancreatitis]]||Etiologies||–||–
|-
| Gastroenterology||[[Pancreatitis]]||Clinical manifestations||–||–
|-
| Gastroenterology||[[Pancreatitis]]||Physical exam||–||–
|-
| Gastroenterology||[[Pancreatitis]]||Diagnostic studies||–||–
|-
| Gastroenterology||[[Pancreatitis]]||Treatment||–||–
|-
| Gastroenterology||[[Pancreatitis]]||Complications||–||Ranson's Criteria
|-
| Gastroenterology||[[Pancreatitis]]||Prognosis||–||Pancreatitis Prognosis by Ranson's Criteria
|-
| Gastroenterology||[[Pancreatitis]]||Chronic Pancreatitis||–||–
|-
| Gastroenterology||[[Abnormal liver tests]]||Tests of hepatocellular injury or cholestasis||–||–
|-
| Gastroenterology||[[Abnormal liver tests]]||Tests of hepatic function||–||–
|-
| Gastroenterology||[[Abnormal liver tests]]||Patterns of liver injury||–||–
|-
| Gastroenterology||[[Abnormal liver tests]]||Abnormal liver tests with hepatocellular pattern||Approach to abnormal liver tests with hepatocellular pattern||–
|-
| Gastroenterology||[[Abnormal liver tests]]||Abnormal liver tests with cholestatic pattern||Approach to abnormal liver tests with cholestatic pattern||–
|-
| Gastroenterology||[[Abnormal liver tests]]||Abnormal liver tests with isolated hyperbilirubinemia||Approach to abnormal liver tests with isolated hyperbilirubinemia||–
|-
| Gastroenterology||[[Abnormal liver tests]]||Abnormal liver tests with infiltrated pattern||Approach to abnormal liver tests with infiltrated pattern||–
|-
| Gastroenterology||[[Abnormal liver tests]]||Abnormal liver tests in asymptomatic patients||–||–
|-
| Gastroenterology||[[Abnormal liver tests]]||Common medications that cause abnormal liver tests||–||Common medications that cause abnormal liver tests
|-
| Gastroenterology||[[Viral hepatitis]]||Hepatitis A||–||–
|-
| Gastroenterology||[[Viral hepatitis]]||Hepatitis B||Serologic Diagnosis of Hepatitis B||–
|-
| Gastroenterology||[[Viral hepatitis]]||Hepatitis B||–||Serology of Hepatitis B
|-
| Gastroenterology||[[Viral hepatitis]]||Hepatitis C||–||–
|-
| Gastroenterology||[[Viral hepatitis]]||Hepatitis D||–||–
|-
| Gastroenterology||[[Viral hepatitis]]||Hepatitis E||–||–
|-
| Gastroenterology||[[Viral hepatitis]]||Other Viruses||–||–
|-
| Gastroenterology||[[Autoimmune hepatitis]]||Classification||–||–
|-
| Gastroenterology||[[Autoimmune hepatitis]]||Diagnosis and treatment||–||–
|-
| Gastroenterology||[[Other causes of hepatitis or hepatotoxicity]]||Alcoholic hepatitis||–||–
|-
| Gastroenterology||[[Other causes of hepatitis or hepatotoxicity]]||Acetaminophen hepatotoxicity||–||–
|-
| Gastroenterology||[[Other causes of hepatitis or hepatotoxicity]]||Ischemic hepatitis||–||–
|-
| Gastroenterology||[[Other causes of hepatitis or hepatotoxicity]]||Nonalcoholic fatty liver disease||–||–
|-
| Gastroenterology||[[Acute liver failure]]||Definition||–||–
|-
| Gastroenterology||[[Acute liver failure]]||Etiology||–||–
|-
| Gastroenterology||[[Acute liver failure]]||Clinical manifestations||–||–
|-
| Gastroenterology||[[Acute liver failure]]||Workup||–||–
|-
| Gastroenterology||[[Acute liver failure]]||Treatment||–||–
|-
| Gastroenterology||[[Acute liver failure]]||Prognosis||–||–
|-
| Gastroenterology||[[Cirrhosis]]||Definition||–||–
|-
| Gastroenterology||[[Cirrhosis]]||Etiologies||–||–
|-
| Gastroenterology||[[Cirrhosis]]||Clinical manifestations||–||–
|-
| Gastroenterology||[[Cirrhosis]]||Physical exam||–||–
|-
| Gastroenterology||[[Cirrhosis]]||Laboratory studies||–||–
|-
| Gastroenterology||[[Cirrhosis]]||Workup||–||–
|-
| Gastroenterology||[[Cirrhosis]]||Ascites||–||–
|-
| Gastroenterology||[[Cirrhosis]]||Spontaneous bacterial peritonitis||–||–
|-
| Gastroenterology||[[Cirrhosis]]||Gastroesophageal varices ± UGIB||–||–
|-
| Gastroenterology||[[Cirrhosis]]||Portosystemic encephalopathy (PSE)||–||–
|-
| Gastroenterology||[[Cirrhosis]]||Hepatorenal syndrome (HRS)||–||–
|-
| Gastroenterology||[[Cirrhosis]]||Hepatocellular carcinoma (HCC)||–||–
|-
| Gastroenterology||[[Cirrhosis]]||Other complications||–||–
|-
| Gastroenterology||[[Cirrhosis]]||Prognosis||–||Modified Child-Turcotte-Pugh Scoring System
|-
| Gastroenterology||[[Cirrhosis]]||Liver transplantation||–||–
|-
| Gastroenterology||[[Other etiologies of cirrhosis]]||Hemochromatosis||–||–
|-
| Gastroenterology||[[Other etiologies of cirrhosis]]||Wilson's disease||–||–
|-
| Gastroenterology||[[Other etiologies of cirrhosis]]||ɑ1-antitrypsin deficiency||–||–
|-
| Gastroenterology||[[Other etiologies of cirrhosis]]||Primary biliary cirrhosis (PBC)||–||–
|-
| Gastroenterology||[[Other etiologies of cirrhosis]]||Primary sclerosing cholangitis (PSC)||–||–
|-
| Gastroenterology||[[Hepatic vascular disease]]||Portal vein thrombosis||–||–
|-
| Gastroenterology||[[Hepatic vascular disease]]||Budd-Chiari syndrome||–||–
|-
| Gastroenterology||[[Hepatic vascular disease]]||Sinusoidal obstruction syndrome||Hepatic vasculature||–
|-
| Gastroenterology||[[Ascites]]||Pathophysiology||–||Etiologies of Ascites
|-
| Gastroenterology||[[Ascites]]||Symptoms||–||–
|-
| Gastroenterology||[[Ascites]]||Evaluation||–||–
|-
| Gastroenterology||[[Ascites]]||Treatment||–||–
|-
| Gastroenterology||[[Ascites]]||Bacterial peritonitis||–||Ascites in Bacterial peritonitis
|-
| Gastroenterology||[[Cholelithiasis]]||Epidemiology & pathogenesis||–||–
|-
| Gastroenterology||[[Cholelithiasis]]||Types of gallstones||–||–
|-
| Gastroenterology||[[Cholelithiasis]]||Clinical manifestations||–||–
|-
| Gastroenterology||[[Cholelithiasis]]||Diagnostic studies||–||–
|-
| Gastroenterology||[[Cholelithiasis]]||Treatment||–||–
|-
| Gastroenterology||[[Cholelithiasis]]||Complications||–||–
|-
| Gastroenterology||[[Cholecystitis]]||Pathogenesis||–||–
|-
| Gastroenterology||[[Cholecystitis]]||Clinical manifestations||–||–
|-
| Gastroenterology||[[Cholecystitis]]||Diagnostic studies||–||–
|-
| Gastroenterology||[[Cholecystitis]]||Treatment||–||–
|-
| Gastroenterology||[[Cholecystitis]]||Complications||–||–
|-
| Gastroenterology||[[Choledocholithiasis]]||Definition||–||–
|-
| Gastroenterology||[[Choledocholithiasis]]||Epidemiology||–||–
|-
| Gastroenterology||[[Choledocholithiasis]]||Clinical manifestations||–||–
|-
| Gastroenterology||[[Choledocholithiasis]]||Diagnostic studies||–||–
|-
| Gastroenterology||[[Choledocholithiasis]]||Treatment||–||–
|-
| Gastroenterology||[[Choledocholithiasis]]||Complications||–||–
|-
| Gastroenterology||[[Cholangitis]]||Definition & etiologies||–||–
|-
| Gastroenterology||[[Cholangitis]]||Clinical manifestations||–||–
|-
| Gastroenterology||[[Cholangitis]]||Diagnostic studies||–||–
|-
| Gastroenterology||[[Cholangitis]]||Treatment||–||–
|-
| Nephrology||[[Acid-base disturbances]]||Consequences of Severe Acid-Base Disturbances||–||Consequences of Severe Acid-Base Disturbances
|-
| Nephrology||[[Acid-base disturbances]]||Workup||–||Acid-Base Disturbances
|-
| Nephrology||[[Acid-base disturbances]]||Compensation for Acid-Base Disturbances||–||Compensation for Acid-Base Disturbances
|-
| Nephrology||[[Acid-base disturbances]]||Acid-base nomogram||Acid-base nomogram||–
|-
| Nephrology||[[Metabolic acidosis]]||Initial workup||Approach to metabolic acidosis||–
|-
| Nephrology||[[Metabolic acidosis]]||Etiologies of AG metabolic acidosis||–||Etiologies of AG metabolic acidosis
|-
| Nephrology||[[Metabolic acidosis]]||Workup for AG metabolic acidosis||–||Manifestations of ingestions causing AG metabolic acidosis
|-
| Nephrology||[[Metabolic acidosis]]||Workup for non-AG metabolic acidosis ||–||Etiologies of non-AG metabolic acidosis
|-
| Nephrology||[[Metabolic acidosis]]||Renal tubular acidosis||–||Renal tubular acidosis
|-
| Nephrology||[[Metabolic acidosis]]||Treatment of severe metabolic acidosis||–||–
|-
| Nephrology||[[Metabolic alkalosis]]||Pathophysiology||–||–
|-
| Nephrology||[[Metabolic alkalosis]]||Workup||Approach to metabolic alkalosis||–
|-
| Nephrology||[[Metabolic alkalosis]]||Etiologies of metabolic alkalosis||–||Etiologies of metabolic alkalosis
|-
| Nephrology||[[Metabolic alkalosis]]||Treatment of severe metabolic alkalosis||–||–
|-
| Nephrology||[[Respiratory acidosis]]||Respiratory Acidosis||–||–
|-
| Nephrology||[[Respiratory alkalosis]]||Respiratory Alkalosis||–||–
|-
| Nephrology||[[Hyponatremia]]||Pathophysiology||Approach to hyponatremia||–
|-
| Nephrology||[[Hyponatremia]]||Workup||–||–
|-
| Nephrology||[[Hyponatremia]]||Hypovolemic hypotonic hyponatremia ||–||–
|-
| Nephrology||[[Hyponatremia]]||Euvolemic hypotonic hyponatremia||–||–
|-
| Nephrology||[[Hyponatremia]]||Hypervolemic hypotonic hyponatremia||–||–
|-
| Nephrology||[[Hyponatremia]]||Treatment||–||–
|-
| Nephrology||[[Hypernatremia]]||Pathophysiology||Approach to hypernatremia||–
|-
| Nephrology||[[Hypernatremia]]||Workup||–||–
|-
| Nephrology||[[Hypernatremia]]||Extrarenal H2O loss||–||–
|-
| Nephrology||[[Hypernatremia]]||Renal H2O loss||–||–
|-
| Nephrology||[[Hypernatremia]]||Other||–||–
|-
| Nephrology||[[Hypernatremia]]||Treatment||–||–
|-
| Nephrology||[[Polyuria]]||Definition and pathophysiology||Approach to polyuria||–
|-
| Nephrology||[[Polyuria]]||Workup||–||–
|-
| Nephrology||[[Polyuria]]||Osmotic diuresis||–||–
|-
| Nephrology||[[Polyuria]]||Water diuresis||–||–
|-
| Nephrology||[[Polyuria]]||Treatment||–||–
|-
| Nephrology||[[Hypokalemia]]||Transcellular shifts||Approach to hypokalemia||–
|-
| Nephrology||[[Hypokalemia]]||GI potassium losses||–||–
|-
| Nephrology||[[Hypokalemia]]||Renal potassium losses||–||–
|-
| Nephrology||[[Hypokalemia]]||Clinical manifestations||–||–
|-
| Nephrology||[[Hypokalemia]]||Workup||–||–
|-
| Nephrology||[[Hypokalemia]]||Treatment||–||–
|-
| Nephrology||[[Hyperkalemia]]||Transcellular shifts||–||–
|-
| Nephrology||[[Hyperkalemia]]||Decreased GFR||–||–
|-
| Nephrology||[[Hyperkalemia]]||Normal GFR but with Ø renal K excretion||–||–
|-
| Nephrology||[[Hyperkalemia]]||Clinical manifestations||–||–
|-
| Nephrology||[[Hyperkalemia]]||Workup||–||Treatment of Hyperkalemia
|-
| Nephrology||[[Acute kidney injury]]||Definition||–||–
|-
| Nephrology||[[Acute kidney injury]]||Workup||–||Etiologies and Diagnosis of Acute Kidney Injury
|-
| Nephrology||[[Acute kidney injury]]||Contrast-induced acute kidney injury (CIAKI)||–||–
|-
| Nephrology||[[Acute kidney injury]]||Treatment||–||–
|-
| Nephrology||[[Chronic kidney disease]]||Definition and etiologies||–||Stages of CKD
|-
| Nephrology||[[Chronic kidney disease]]||Treatment||–||Signs and Symptoms of Uremia
|-
| Nephrology||[[Diuresis]]||General considerations||–||Approach to Diuresis
|-
| Nephrology||[[Diuresis]]||Loop diuretics||–||–
|-
| Nephrology||[[Diuresis]]||Thiazide diuretics||–||–
|-
| Nephrology||[[Diuresis]]||K-sparing diuretics||–||–
|-
| Nephrology||[[Diuresis]]||Disease state specific regimens||–||–
|-
| Nephrology||[[Diuresis]]||Adverse effects||–||–
|-
| Nephrology||[[Renal replacement and dialysis]]||General||–||–
|-
| Nephrology||[[Renal replacement and dialysis]]||Hemodialysis (HD)||–||–
|-
| Nephrology||[[Renal replacement and dialysis]]||Continuous veno-venous hemofiltration (CVVH)||–||–
|-
| Nephrology||[[Renal replacement and dialysis]]||Peritoneal dialysis (PD)||–||–
|-
| Nephrology||[[Renal replacement and dialysis]]||Kidney transplantation||–||–
|-
| Nephrology||[[Glomerulonephritis]]||Definition||Approach to glomerulonephritis||–
|-
| Nephrology||[[Glomerulonephritis]]||ANCA-Positive Vasculitis||–||ANCA-Positive Vasculitis
|-
| Nephrology||[[Glomerulonephritis]]||Anti-GBM Disease||–||Anti-GBM Disease
|-
| Nephrology||[[Glomerulonephritis]]||Immune Complex Disease||–||Immune Complex Disease
|-
| Nephrology||[[Glomerulonephritis]]||Workup||–||–
|-
| Nephrology||[[Glomerulonephritis]]||Treatment||–||–
|-
| Nephrology||[[Asymptomatic glomerular hematuria]]||Definition and etiologies||–||–
|-
| Nephrology||[[Asymptomatic glomerular hematuria]]||IgA nephropathy||–||–
|-
| Nephrology||[[Nephrotic syndrome]]||Definition||–||–
|-
| Nephrology||[[Nephrotic syndrome]]||Primary glomerular diseases||–||–
|-
| Nephrology||[[Nephrotic syndrome]]||Systemic diseases||–||–
|-
| Nephrology||[[Nephrotic syndrome]]||Workup||–||–
|-
| Nephrology||[[Nephrotic syndrome]]||Treatment||–||–
|-
| Nephrology||[[Urinalysis]]||Urine Dipstick||–||Urine Dipstick
|-
| Nephrology||[[Urinalysis]]||Urine Sediment||–||Urine Sediment
|-
| Nephrology||[[Proteinuria]]||Proteinuria||–||Etiologies of Proteinuria
|-
| Nephrology||[[Hematuria]]||Workup||–||Etiologies of Hematuria
|-
| Nephrology||[[Nephrolithiasis]]||Types of stones and risk factors||–||–
|-
| Nephrology||[[Nephrolithiasis]]||Clinical manifestations||–||–
|-
| Nephrology||[[Nephrolithiasis]]||Workup||–||–
|-
| Nephrology||[[Nephrolithiasis]]||Acute treatment||–||–
|-
| Nephrology||[[Nephrolithiasis]]||Chronic treatment||–||–
|-
| Hematology-Oncology||[[Anemia]]||Clinical manifestations||–||–
|-
| Hematology-Oncology||[[Anemia]]||Diagnostic evaluation||Approach to anemia||–
|-
| Hematology-Oncology||[[Microcytic anemia]]||Approach to microcytic anemias||Approach to microcytic anemias||–
|-
| Hematology-Oncology||[[Microcytic anemia]]||Iron deficiency ||–||–
|-
| Hematology-Oncology||[[Microcytic anemia]]||Thalassemias||–||–
|-
| Hematology-Oncology||[[Microcytic anemia]]||Anemia of chronic inflammation||–||–
|-
| Hematology-Oncology||[[Microcytic anemia]]||Sideroblastic anemia||–||–
|-
| Hematology-Oncology||[[Normocytic anemia]]||Pancytopenia||–||–
|-
| Hematology-Oncology||[[Normocytic anemia]]||Anemia of chronic inflammation||–||–
|-
| Hematology-Oncology||[[Normocytic anemia]]||Anemias of chronic disorders||–||–
|-
| Hematology-Oncology||[[Normocytic anemia]]||Sideroblastic anemia||–||–
|-
| Hematology-Oncology||[[Normocytic anemia]]||Pure red cell aplasia||–||–
|-
| Hematology-Oncology||[[Macrocytic anemia]]||Megaloblastic anemia||–||–
|-
| Hematology-Oncology||[[Macrocytic anemia]]||Folate deficiency||–||–
|-
| Hematology-Oncology||[[Macrocytic anemia]]||Vitamin B12 deficiency||–||–
|-
| Hematology-Oncology||[[Macrocytic anemia]]||Nonmegaloblastic macrocytic anemias||–||–
|-
| Hematology-Oncology||[[Pancytopenia]]||Etiologies||–||–
|-
| Hematology-Oncology||[[Pancytopenia]]||Clinical manifestations||–||–
|-
| Hematology-Oncology||[[Pancytopenia]]||Aplastic anemia||–||–
|-
| Hematology-Oncology||[[Pancytopenia]]||Myelodysplastic syndromes (MDS)||–||–
|-
| Hematology-Oncology||[[Pancytopenia]]||Paroxysmal nocturnal hemoglobinuria (PNH)||–||–
|-
| Hematology-Oncology||[[Pancytopenia]]||Myelophthisic anemia||–||–
|-
| Hematology-Oncology||[[Hemolytic anemia]]||Diagnostic evaluation||–||Causes of Hemolytic Anemia by Mechanism
|-
| Hematology-Oncology||[[Hemolytic anemia]]||Glucose-6-phosphate dehydrogenase (G6PD) deficiency||–||–
|-
| Hematology-Oncology||[[Hemolytic anemia]]||Sickle cell anemia||–||–
|-
| Hematology-Oncology||[[Hemolytic anemia]]||Hereditary spherocytosis (HS)||–||–
|-
| Hematology-Oncology||[[Hemolytic anemia]]||Autoimmune hemolytic anemia (AIHA)||–||–
|-
| Hematology-Oncology||[[Hemolytic anemia]]||Drug-induced hemolytic anemia||–||–
|-
| Hematology-Oncology||[[Hemolytic anemia]]||Microangiopathic hemolytic anemia (MAHA)||–||–
|-
| Hematology-Oncology||[[Hemolytic anemia]]||Hypersplenism||–||Causes of Splenomegaly
|-
| Hematology-Oncology||[[Disorders of hemostasis]]||Approach to abnormal hemostasis||Approach to abnormal hemostasis||–
|-
| Hematology-Oncology||[[Disorders of hemostasis]]||Clinical Characteristics of Bleeding Disorders||–||Clinical Characteristics of Bleeding Disorders
|-
| Hematology-Oncology||[[Disorders of hemostasis]]||Coagulation Cascade||Coagulation Cascade||–
|-
| Hematology-Oncology||[[Disorders of hemostasis]]||Purpura||–||–
|-
| Hematology-Oncology||[[Thrombocytopenia]]||Etiologies||Approach to thrombocytopenia||–
|-
| Hematology-Oncology||[[Thrombocytopenia]]||Thrombocytopenia and Risk of Bleeding||–||Thrombocytopenia and Risk of Bleeding
|-
| Hematology-Oncology||[[Thrombocytopenia]]||Diagnostic evaluation||–||–
|-
| Hematology-Oncology||[[Thrombocytopenia]]||Primary immune thrombocytopenic purpura (ITP)||–||Treatment of Primary ITP in Adults
|-
| Hematology-Oncology||[[Thrombocytopenia]]||Heparin-Induced Thrombocytopenia||–||Overview of Heparin-Induced Thrombocytopenia
|-
| Hematology-Oncology||[[Thrombocytopenia]]||Evaluation of Suspected HIT||–||Evaluation of Suspected HIT
|-
| Hematology-Oncology||[[Thrombocytopenia]]||Hemolytic-uremic syndrome (HUS)||–||–
|-
| Hematology-Oncology||[[Thrombocytopenia]]||Thrombotic thrombocytopenic purpura (TTP)||–||–
|-
| Hematology-Oncology||[[Disorders of platelet function]]||Tests of platelet function||–||Mechanisms and Etiologies of Platelet Function Abnormalities
|-
| Hematology-Oncology||[[Disorders of platelet function]]||von Willebrand’s disease (vWD)||–||–
|-
| Hematology-Oncology||[[Disorders of platelet function]]||Uremic bleeding||–||–
|-
| Hematology-Oncology||[[Coagulopathies]]||Screening Test Abnormalities in Inherited and Acquired Coagulopathies||–||Screening Test Abnormalities in Inherited and Acquired Coagulopathies
|-
| Hematology-Oncology||[[Coagulopathies]]||Further coagulation tests||–||–
|-
| Hematology-Oncology||[[Coagulopathies]]||Hemophilias||–||–
|-
| Hematology-Oncology||[[Coagulopathies]]||Coagulation factor inhibitors||–||–
|-
| Hematology-Oncology||[[Coagulopathies]]||Disseminated intravascular coagulation (DIC)||–||–
|-
| Hematology-Oncology||[[Coagulopathies]]||Vitamin K deficiency||–||Properties and Antidotes for Anticoagulants and Fibrinolytics
|-
| Hematology-Oncology||[[Hypercoagulable states]]||Inherited Hypercoagulable States||–||Inherited Hypercoagulable States
|-
| Hematology-Oncology||[[Hypercoagulable states]]||Vascular Beds Affected by Inherited and Acquired Hypercoagulable States||–||Vascular Beds Affected by Inherited and Acquired Hypercoagulable States
|-
| Hematology-Oncology||[[Hypercoagulable states]]||Diagnostic evaluation||–||–
|-
| Hematology-Oncology||[[Hypercoagulable states]]||Treatment||–||–
|-
| Hematology-Oncology||[[Hypercoagulable states]]||Antiphospholipid syndrome (APS)||–||–
|-
| Hematology-Oncology||[[Disorders of leukocytes]]||Neutrophilia||–||Neutrophilia
|-
| Hematology-Oncology||[[Disorders of leukocytes]]||Neutropenia||–||Neutropenia
|-
| Hematology-Oncology||[[Disorders of leukocytes]]||Lymphocytosis||–||Lymphocytosis
|-
| Hematology-Oncology||[[Disorders of leukocytes]]||Monocytosis||–||Monocytosis
|-
| Hematology-Oncology||[[Disorders of leukocytes]]||Eosinophilia||–||Eosinophilia
|-
| Hematology-Oncology||[[Disorders of leukocytes]]||Basophilia||–||Basophilia
|-
| Hematology-Oncology||[[Disorders of leukocytes]]||Lymphadenopathy||–||Lymphadenopathy
|-
| Hematology-Oncology||[[Transfusion therapy]]||Blood Products and Indications||–||Blood Products and Indications
|-
| Hematology-Oncology||[[Transfusion therapy]]||Transfusion Complications||–||Transfusion Complications
|-
| Hematology-Oncology||[[Transfusion therapy]]||Transfusion Reactions||–||Transfusion Reactions
|-
| Hematology-Oncology||[[Myelodysplastic syndromes]]||Myeloid neoplasm overview||–||WHO 2008 Myeloid Neoplasm Categories
|-
| Hematology-Oncology||[[Myelodysplastic syndromes]]||Myelodysplastic syndromes (MDS) overview||–||WHO 2008 Classification Systems for MDS
|-
| Hematology-Oncology||[[Myelodysplastic syndromes]]||Revised International Prognostic Scoring System||–||Revised International Prognostic Scoring System for AML
|-
| Hematology-Oncology||[[Myeloproliferative neoplasms (mpn)]]||Myeloproliferative Neoplasms (MPN)||–||–
|-
| Hematology-Oncology||[[Polycythemia vera (pv)]]||Definition||–||–
|-
| Hematology-Oncology||[[Polycythemia vera (pv)]]||Etiologies of erythrocytosis||–||–
|-
| Hematology-Oncology||[[Polycythemia vera (pv)]]||Clinical manifestations||–||–
|-
| Hematology-Oncology||[[Polycythemia vera (pv)]]||Diagnostic evaluation||–||–
|-
| Hematology-Oncology||[[Polycythemia vera (pv)]]||Treatment||–||–
|-
| Hematology-Oncology||[[Polycythemia vera (pv)]]||Prognosis||–||–
|-
| Hematology-Oncology||[[Essential thrombocythemia (et)]]||Definition||–||–
|-
| Hematology-Oncology||[[Essential thrombocythemia (et)]]||Etiologies of thrombocytosis||–||–
|-
| Hematology-Oncology||[[Essential thrombocythemia (et)]]||Clinical manifestations||–||–
|-
| Hematology-Oncology||[[Essential thrombocythemia (et)]]||Diagnostic evaluation||–||–
|-
| Hematology-Oncology||[[Essential thrombocythemia (et)]]||Prognosis||–||–
|-
| Hematology-Oncology||[[Primary myelofibrosis (pmf)]]||Definition||–||–
|-
| Hematology-Oncology||[[Primary myelofibrosis (pmf)]]||Etiologies of myelofibrosis||–||–
|-
| Hematology-Oncology||[[Primary myelofibrosis (pmf)]]||Clinical manifestations||–||–
|-
| Hematology-Oncology||[[Primary myelofibrosis (pmf)]]||Diagnostic evaluation||–||–
|-
| Hematology-Oncology||[[Primary myelofibrosis (pmf)]]||Treatment||–||–
|-
| Hematology-Oncology||[[Primary myelofibrosis (pmf)]]||Complications and prognosis||–||–
|-
| Hematology-Oncology||[[Acute leukemia]]||Definition||–||–
|-
| Hematology-Oncology||[[Acute leukemia]]||Epidemiology and risk factors||–||–
|-
| Hematology-Oncology||[[Acute leukemia]]||Clinical manifestations||–||–
|-
| Hematology-Oncology||[[Acute leukemia]]||Diagnostic evaluation||–||–
|-
| Hematology-Oncology||[[Acute myelogenous leukemia (aml)]]||Classification||–||WHO 2008 Classification of AML
|-
| Hematology-Oncology||[[Acute myelogenous leukemia (aml)]]||Treatment||–||AML Genetics
|-
| Hematology-Oncology||[[Acute myelogenous leukemia (aml)]]||Prognosis||–||–
|-
| Hematology-Oncology||[[Acute myelogenous leukemia (aml)]]||Acute Promyelocytic Leukemia (APL)||–||–
|-
| Hematology-Oncology||[[Acute lymphoblastic leukemia (all)]]||Classification||–||WHO Immunophenotype Classification of ALL
|-
| Hematology-Oncology||[[Acute lymphoblastic leukemia (all)]]||Treatment||–||–
|-
| Hematology-Oncology||[[Acute lymphoblastic leukemia (all)]]||Prognosis||–||–
|-
| Hematology-Oncology||[[Chronic myelogenous leukemia (cml)]]||Definition||–||–
|-
| Hematology-Oncology||[[Chronic myelogenous leukemia (cml)]]||Epidemiology and risk factors||–||–
|-
| Hematology-Oncology||[[Chronic myelogenous leukemia (cml)]]||Clinical manifestations||–||–
|-
| Hematology-Oncology||[[Chronic myelogenous leukemia (cml)]]||Diagnostic evaluation||–||–
|-
| Hematology-Oncology||[[Chronic myelogenous leukemia (cml)]]||Treatment||–||Goals of TKI Therapy
|-
| Hematology-Oncology||[[Chronic myelogenous leukemia (cml)]]||Prognosis||–||–
|-
| Hematology-Oncology||[[Chronic lymphocytic leukemia (cll)]]||Definition||–||–
|-
| Hematology-Oncology||[[Chronic lymphocytic leukemia (cll)]]||Epidemiology and risk factors||–||–
|-
| Hematology-Oncology||[[Chronic lymphocytic leukemia (cll)]]||Clinical manifestations||–||–
|-
| Hematology-Oncology||[[Chronic lymphocytic leukemia (cll)]]||Diagnostic evaluation||–||CLL Staging
|-
| Hematology-Oncology||[[Chronic lymphocytic leukemia (cll)]]||Treatment||–||–
|-
| Hematology-Oncology||[[Chronic lymphocytic leukemia (cll)]]||Prognosis||–||–
|-
| Hematology-Oncology||[[Lymphoma]]||Definition||–||–
|-
| Hematology-Oncology||[[Lymphoma]]||Clinical manifestations||–||–
|-
| Hematology-Oncology||[[Lymphoma]]||Diagnostic and staging evaluation||–||Ann Arbor Staging System with Cotswolds Modifications
|-
| Hematology-Oncology||[[Hodgkin lymphoma (hl)]]||Epidemiology and risk factors||–||–
|-
| Hematology-Oncology||[[Hodgkin lymphoma (hl)]]||Pathology||–||WHO Histologic Classification of Classical HL
|-
| Hematology-Oncology||[[Hodgkin lymphoma (hl)]]||Treatment||–||International Prognostic Score (IPS)
|-
| Hematology-Oncology||[[Non-hodgkin lymphoma (nhl)]]||Epidemiology and risk factors||–||WHO Classification of Lymphoid Malignancies
|-
| Hematology-Oncology||[[Non-hodgkin lymphoma (nhl)]]||Treatment||–||–
|-
| Hematology-Oncology||[[Non-hodgkin lymphoma (nhl)]]||Prognosis||–||Follicular Lymphoma International Prognostic Index (FLIPI)
|-
| Hematology-Oncology||[[Non-hodgkin lymphoma (nhl)]]||HIV-associated NHL||–||International Prognostic Index (IPI) for Aggressive NHL
|-
| Hematology-Oncology||[[Multiple myeloma]]||Definition and epidemiology||–||–
|-
| Hematology-Oncology||[[Multiple myeloma]]||Clinical manifestations||–||–
|-
| Hematology-Oncology||[[Multiple myeloma]]||Diagnostic and staging evaluation||–||Multiple Myeloma Staging Systems
|-
| Hematology-Oncology||[[Multiple myeloma]]||Treatment||–||–
|-
| Hematology-Oncology||[[Monoclonal gammopathy of uncertain significance]]||Definition and epidemiology||–||–
|-
| Hematology-Oncology||[[Monoclonal gammopathy of uncertain significance]]||Management||–||–
|-
| Hematology-Oncology||[[Monoclonal gammopathy of uncertain significance]]||Prognosis||–||–
|-
| Hematology-Oncology||[[Waldenstrom's macroglobulinemia]]||Definition||–||–
|-
| Hematology-Oncology||[[Waldenstrom's macroglobulinemia]]||Clinical manifestations||–||–
|-
| Hematology-Oncology||[[Waldenstrom's macroglobulinemia]]||Diagnostic evaluation||–||–
|-
| Hematology-Oncology||[[Waldenstrom's macroglobulinemia]]||Treatment||–||–
|-
| Hematology-Oncology||[[Hematopoietic stem cell transplantation]]||Indications||–||Categories of Stem Cell Transplantation
|-
| Hematology-Oncology||[[Hematopoietic stem cell transplantation]]||Transplantation procedure||–||Prophylaxis and Supportive Medications during HSCT
|-
| Hematology-Oncology||[[Hematopoietic stem cell transplantation]]||Complications||–||Timing of Complications following Allogeneic HSCT
|-
| Hematology-Oncology||[[Lung cancer]]||Pathology and Genetics of Lung Cancer||–||Pathology and Genetics of Lung Cancer
|-
| Hematology-Oncology||[[Lung cancer]]||Epidemiology and risk factors||–||–
|-
| Hematology-Oncology||[[Lung cancer]]||Clinical manifestations||–||–
|-
| Hematology-Oncology||[[Lung cancer]]||Screening||–||–
|-
| Hematology-Oncology||[[Lung cancer]]||Diagnostic and staging evaluation||–||TNM Staging System for NSCLC
|-
| Hematology-Oncology||[[Lung cancer]]||NSCLC Treatment||–||NSCLC Simplified Staging Schema
|-
| Hematology-Oncology||[[Lung cancer]]||SCLC Treatment||–||–
|-
| Hematology-Oncology||[[Breast cancer]]||Epidemiology and genetics||–||–
|-
| Hematology-Oncology||[[Breast cancer]]||Clinical manifestations||–||–
|-
| Hematology-Oncology||[[Breast cancer]]||Screening||–||–
|-
| Hematology-Oncology||[[Breast cancer]]||Diagnostic evaluation||–||–
|-
| Hematology-Oncology||[[Breast cancer]]||Staging||–||Simplified Staging System for Breast Cancer
|-
| Hematology-Oncology||[[Breast cancer]]||Treatment||–||Treatment of Carcinoma in situ and Invasive Carcinoma of the Breast
|-
| Hematology-Oncology||[[Breast cancer]]||Prevention||–||–
|-
| Hematology-Oncology||[[Prostate cancer]]||Epidemiology and risk factors||–||–
|-
| Hematology-Oncology||[[Prostate cancer]]||Clinical manifestations||–||–
|-
| Hematology-Oncology||[[Prostate cancer]]||Screening||–||–
|-
| Hematology-Oncology||[[Prostate cancer]]||Diagnostic and staging evaluation||–||TNM Staging and Treatment of Prostate Cancer
|-
| Hematology-Oncology||[[Prostate cancer]]||Prognosis||–||–
|-
| Hematology-Oncology||[[Prostate cancer]]||Prevention||–||–
|-
| Hematology-Oncology||[[Colorectal cancer]]||Epidemiology and risk factors||–||–
|-
| Hematology-Oncology||[[Colorectal cancer]]||Pathology and genetics||–||–
|-
| Hematology-Oncology||[[Colorectal cancer]]||Clinical manifestations||–||–
|-
| Hematology-Oncology||[[Colorectal cancer]]||Screening||–||–
|-
| Hematology-Oncology||[[Colorectal cancer]]||Staging||–||Treatment Based on TNM and Modified Dukes Staging of Colorectal Cancer
|-
| Hematology-Oncology||[[Chemotherapy side effects]]||Chemotherapy Side Effects||–||Select Adverse Effects from Chemotherapy
|-
| Hematology-Oncology||[[Pancreatic tumors]]||Pathology and genetics||–||–
|-
| Hematology-Oncology||[[Pancreatic tumors]]||Epidemiology and risk factors||–||–
|-
| Hematology-Oncology||[[Pancreatic tumors]]||Clinical manifestations||–||–
|-
| Hematology-Oncology||[[Pancreatic tumors]]||Diagnostic and staging evaluation||–||Staging and Prognosis of Pancreatic Adenocarcinoma
|-
| Hematology-Oncology||[[Pancreatic tumors]]||Treatment of pancreatic adenocarcinoma||–||–
|-
| Hematology-Oncology||[[Pancreatic tumors]]||Cystic lesions of the pancreas||–||–
|-
| Hematology-Oncology||[[Fever and neutropenia]]||Definition||–||–
|-
| Hematology-Oncology||[[Fever and neutropenia]]||Pathophysiology and microbiology||–||–
|-
| Hematology-Oncology||[[Fever and neutropenia]]||Prevention||–||–
|-
| Hematology-Oncology||[[Fever and neutropenia]]||Diagnostic evaluation||–||–
|-
| Hematology-Oncology||[[Fever and neutropenia]]||Risk stratification||–||–
|-
| Hematology-Oncology||[[Fever and neutropenia]]||Initial antibiotic therapy||–||–
|-
| Hematology-Oncology||[[Fever and neutropenia]]||Modification to initial antibiotic regimen||–||–
|-
| Hematology-Oncology||[[Fever and neutropenia]]||Duration of therapy||–||–
|-
| Hematology-Oncology||[[Fever and neutropenia]]||Role of hematopoietic growth factors||–||–
|-
| Hematology-Oncology||[[Spinal cord compression]]||Clinical manifestations||–||–
|-
| Hematology-Oncology||[[Spinal cord compression]]||Diagnostic evaluation||–||–
|-
| Hematology-Oncology||[[Spinal cord compression]]||Treatment||–||–
|-
| Hematology-Oncology||[[Tumor lysis syndrome]]||Clinical manifestations||–||–
|-
| Hematology-Oncology||[[Tumor lysis syndrome]]||Prophylaxis||–||–
|-
| Hematology-Oncology||[[Tumor lysis syndrome]]||Treatment||–||–
|-
| Hematology-Oncology||[[Cancer of unknown primary site]]||Cancer of Unknown Primary Site||–||Evaluation of Cancer of Unknown Primary Site
|-
| Infectious Diseases||[[Pneumonia]]||Microbiology of Pneumonia||–||Microbiology of Pneumonia
|-
| Infectious Diseases||[[Pneumonia]]||Clinical manifestations||–||–
|-
| Infectious Diseases||[[Pneumonia]]||Diagnostic studies||–||–
|-
| Infectious Diseases||[[Pneumonia]]||Prognosis||–||–
|-
| Infectious Diseases||[[Pneumonia]]||Treatment||–||Treatment of Pneumonia
|-
| Infectious Diseases||[[Pneumonia]]||Prevention||–||–
|-
| Infectious Diseases||[[Viral respiratory infections]]||Microbiology & epidemiology||–||–
|-
| Infectious Diseases||[[Viral respiratory infections]]||Diagnosis||–||–
|-
| Infectious Diseases||[[Viral respiratory infections]]||Treatment||–||–
|-
| Infectious Diseases||[[Viral respiratory infections]]||Prevention||–||–
|-
| Infectious Diseases||[[Fungal infections]]||Candida species||–||Treatment of Candidiasis
|-
| Infectious Diseases||[[Fungal infections]]||Cryptococcus||–||–
|-
| Infectious Diseases||[[Fungal infections]]||Histoplasmosis||–||–
|-
| Infectious Diseases||[[Fungal infections]]||Coccidioidomycosis||–||–
|-
| Infectious Diseases||[[Fungal infections]]||Blastomycosis||–||–
|-
| Infectious Diseases||[[Fungal infections]]||Aspergillosis||–||–
|-
| Infectious Diseases||[[Fungal infections]]||Zygomycetes||–||–
|-
| Infectious Diseases||[[Fungal infections]]||Fungal diagnostics||–||–
|-
| Infectious Diseases||[[Infections in immunocompromised hosts]]||Classic Infectious Etiologies in Immunocompromised Hosts||–||Classic Infectious Etiologies in Immunocompromised Hosts
|-
| Infectious Diseases||[[Urinary tract infection]]||Definitions||–||–
|-
| Infectious Diseases||[[Urinary tract infection]]||Microbiology||–||–
|-
| Infectious Diseases||[[Urinary tract infection]]||Clinical manifestations||–||–
|-
| Infectious Diseases||[[Urinary tract infection]]||Diagnostic studies||–||–
|-
| Infectious Diseases||[[Urinary tract infection]]||Treatment||–||Treatment of UTI
|-
| Infectious Diseases||[[Cellulitis]]||Microbiology & clinical||–||–
|-
| Infectious Diseases||[[Cellulitis]]||Diagnosis||–||Microbiology of Bite Infections
|-
| Infectious Diseases||[[Cellulitis]]||Treatment||–||Treatment of Cellulitis
|-
| Infectious Diseases||[[Other cutaneous infections]]||Other Cutaneous Infections||–||Other Cutaneous Infections
|-
| Infectious Diseases||[[Diabetic foot]]||Microbiology||–||–
|-
| Infectious Diseases||[[Diabetic foot]]||Clinical manifestations||–||–
|-
| Infectious Diseases||[[Diabetic foot]]||Diagnostic studies||–||–
|-
| Infectious Diseases||[[Diabetic foot]]||Treatment||–||Treatment of Diabetic Foot
|-
| Infectious Diseases||[[Necrotizing fasciitis]]||Definition||–||–
|-
| Infectious Diseases||[[Necrotizing fasciitis]]||Epidemiology||–||–
|-
| Infectious Diseases||[[Necrotizing fasciitis]]||Microbiology||–||–
|-
| Infectious Diseases||[[Necrotizing fasciitis]]||Clinical manifestations||–||–
|-
| Infectious Diseases||[[Necrotizing fasciitis]]||Diagnostic signs||–||–
|-
| Infectious Diseases||[[Necrotizing fasciitis]]||Treatment||–||–
|-
| Infectious Diseases||[[Necrotizing fasciitis]]||Prognosis||–||–
|-
| Infectious Diseases||[[Clostridial myonecrosis]]||Definition||–||–
|-
| Infectious Diseases||[[Clostridial myonecrosis]]||Clinical manifestations||–||–
|-
| Infectious Diseases||[[Clostridial myonecrosis]]||Diagnostic signs||–||–
|-
| Infectious Diseases||[[Clostridial myonecrosis]]||Treatment||–||–
|-
| Infectious Diseases||[[Osteomyelitis]]||Microbiology||–||–
|-
| Infectious Diseases||[[Osteomyelitis]]||Clinical manifestations||–||–
|-
| Infectious Diseases||[[Osteomyelitis]]||Diagnostic studies||–||–
|-
| Infectious Diseases||[[Osteomyelitis]]||Treatment||–||–
|-
| Infectious Diseases||[[Epidural abscess]]||Etiology||–||–
|-
| Infectious Diseases||[[Epidural abscess]]||Clinical manifestations||–||–
|-
| Infectious Diseases||[[Epidural abscess]]||Diagnostic studies||–||–
|-
| Infectious Diseases||[[Epidural abscess]]||Treatment||–||–
|-
| Infectious Diseases||[[Acute bacterial meningitis]]||Definition||–||Microbiology in Adult Meningitis
|-
| Infectious Diseases||[[Acute bacterial meningitis]]||Clinical manifestations||–||–
|-
| Infectious Diseases||[[Acute bacterial meningitis]]||Physical exam||–||–
|-
| Infectious Diseases||[[Acute bacterial meningitis]]||Diagnostic studies||–||–
|-
| Infectious Diseases||[[Acute bacterial meningitis]]||Recurrent meningitis||–||Typical CSF Findings in Meningitis
|-
| Infectious Diseases||[[Acute bacterial meningitis]]||Treatment||–||Treatment of Meningitis
|-
| Infectious Diseases||[[Acute bacterial meningitis]]||Prognosis||–||–
|-
| Infectious Diseases||[[Aseptic meningitis]]||Definition||–||–
|-
| Infectious Diseases||[[Aseptic meningitis]]||Etiologies||–||–
|-
| Infectious Diseases||[[Aseptic meningitis]]||Empiric treatment||–||–
|-
| Infectious Diseases||[[Encephalitis]]||Definition||–||–
|-
| Infectious Diseases||[[Encephalitis]]||Etiologies||–||–
|-
| Infectious Diseases||[[Encephalitis]]||Clinical manifestations||–||–
|-
| Infectious Diseases||[[Encephalitis]]||Diagnostic studies||–||–
|-
| Infectious Diseases||[[Encephalitis]]||Treatment||–||–
|-
| Infectious Diseases||[[Bell's palsy]]||Definition & etiologies||–||–
|-
| Infectious Diseases||[[Bell's palsy]]||Clinical manifestations||–||–
|-
| Infectious Diseases||[[Bell's palsy]]||Diagnosis||–||–
|-
| Infectious Diseases||[[Bell's palsy]]||Treatment||–||–
|-
| Infectious Diseases||[[Zoster]]||Definition & etiology||–||–
|-
| Infectious Diseases||[[Zoster]]||Clinical manifestations||–||–
|-
| Infectious Diseases||[[Zoster]]||Diagnosis||–||–
|-
| Infectious Diseases||[[Zoster]]||Treatment||–||–
|-
| Infectious Diseases||[[Bacterial endocarditis]]||Definition||–||Microbiology of Endocarditis
|-
| Infectious Diseases||[[Bacterial endocarditis]]||Predisposing conditions||–||Modified Duke Criteria for Endocarditis
|-
| Infectious Diseases||[[Bacterial endocarditis]]||Clinical manifestations||–||–
|-
| Infectious Diseases||[[Bacterial endocarditis]]||Physical exam||–||–
|-
| Infectious Diseases||[[Bacterial endocarditis]]||Diagnostic studies||–||–
|-
| Infectious Diseases||[[Bacterial endocarditis]]||Treatment||–||–
|-
| Infectious Diseases||[[Bacterial endocarditis]]||Indications for surgery||–||–
|-
| Infectious Diseases||[[Bacterial endocarditis]]||Prognosis||–||Endocarditis prophylaxis
|-
| Infectious Diseases||[[Bacteremia]]||Etiologies||–||–
|-
| Infectious Diseases||[[Bacteremia]]||Microbiology||–||–
|-
| Infectious Diseases||[[Bacteremia]]||Risk factors for true bacteremia ||–||–
|-
| Infectious Diseases||[[Bacteremia]]||Diagnosis||–||–
|-
| Infectious Diseases||[[Bacteremia]]||Treatment||–||–
|-
| Infectious Diseases||[[Tuberculosis]]||Epidemiology||–||–
|-
| Infectious Diseases||[[Tuberculosis]]||Microbiology & natural history||–||–
|-
| Infectious Diseases||[[Tuberculosis]]||Screening for prior infection||–||–
|-
| Infectious Diseases||[[Tuberculosis]]||Clinical manifestations||–||–
|-
| Infectious Diseases||[[Tuberculosis]]||Diagnostic studies for active TB||–||–
|-
| Infectious Diseases||[[Tuberculosis]]||Preventive therapy||–||Prophylactic Regimen for TB
|-
| Infectious Diseases||[[Tuberculosis]]||Treatment of active tuberculosis||–||Antituberculous Medications
|-
| Infectious Diseases||[[Tuberculosis]]||Antituberculous Treatment Regimens||–||Antituberculous Treatment Regimens
|-
| Infectious Diseases||[[Hiv/aids]]||Definition||–||–
|-
| Infectious Diseases||[[Hiv/aids]]||Epidemiology||–||–
|-
| Infectious Diseases||[[Hiv/aids]]||Acute retroviral syndrome||–||–
|-
| Infectious Diseases||[[Hiv/aids]]||Diagnostic studies||–||–
|-
| Infectious Diseases||[[Hiv/aids]]||Approach to newly diagnosed HIV pt||–||Antiretrovirals and Side Effects
|-
| Infectious Diseases||[[Hiv/aids]]||Approach to previously established HIV pt||–||–
|-
| Infectious Diseases||[[Hiv/aids]]||Opportunistic infection prophylaxis||–||Opportunistic infection prophylaxis
|-
| Infectious Diseases||[[Complications of hiv/aids]]||Fever||–||–
|-
| Infectious Diseases||[[Complications of hiv/aids]]||Cutaneous||–||–
|-
| Infectious Diseases||[[Complications of hiv/aids]]||Ophthalmologic||–||–
|-
| Infectious Diseases||[[Complications of hiv/aids]]||Oral||–||–
|-
| Infectious Diseases||[[Complications of hiv/aids]]||Endocrine/metabolic||–||–
|-
| Infectious Diseases||[[Complications of hiv/aids]]||Cardiac||–||–
|-
| Infectious Diseases||[[Complications of hiv/aids]]||Pulmonary||–||–
|-
| Infectious Diseases||[[Complications of hiv/aids]]||Gastrointestinal & hepatobiliary||–||–
|-
| Infectious Diseases||[[Complications of hiv/aids]]||Renal||–||–
|-
| Infectious Diseases||[[Complications of hiv/aids]]||Hematologic/oncologic||–||–
|-
| Infectious Diseases||[[Complications of hiv/aids]]||Neurologic||–||–
|-
| Infectious Diseases||[[Complications of hiv/aids]]||Disseminated Mycobacterium avium complex||–||–
|-
| Infectious Diseases||[[Complications of hiv/aids]]||Cytomegalovirus||–||–
|-
| Infectious Diseases||[[Tick-borne illness]]||Distinguishing features of tick-borne illnesses||–||Distinguishing features of tick-borne illnesses
|-
| Infectious Diseases||[[Lyme disease]]||Microbiology||–||–
|-
| Infectious Diseases||[[Lyme disease]]||Epidemiology||–||–
|-
| Infectious Diseases||[[Lyme disease]]||Diagnostic studies||–||–
|-
| Infectious Diseases||[[Lyme disease]]||Treatment||–||–
|-
| Infectious Diseases||[[Rocky mountain spotted fever]]||Microbiology & epidemiology||–||–
|-
| Infectious Diseases||[[Rocky mountain spotted fever]]||Clinical manifestations||–||–
|-
| Infectious Diseases||[[Rocky mountain spotted fever]]||Diagnosis||–||–
|-
| Infectious Diseases||[[Rocky mountain spotted fever]]||Treatment||–||–
|-
| Infectious Diseases||[[Ehrlichiosis/anaplasmosis]]||Microbiology||–||–
|-
| Infectious Diseases||[[Ehrlichiosis/anaplasmosis]]||Epidemiology||–||–
|-
| Infectious Diseases||[[Ehrlichiosis/anaplasmosis]]||Clinical manifestations||–||–
|-
| Infectious Diseases||[[Ehrlichiosis/anaplasmosis]]||Diagnosis||–||–
|-
| Infectious Diseases||[[Ehrlichiosis/anaplasmosis]]||Treatment||–||–
|-
| Infectious Diseases||[[Babesiosis]]||Microbiology & epidemiology||–||–
|-
| Infectious Diseases||[[Babesiosis]]||Clinical manifestations||–||–
|-
| Infectious Diseases||[[Babesiosis]]||Diagnosis||–||–
|-
| Infectious Diseases||[[Babesiosis]]||Treatment||–||–
|-
| Infectious Diseases||[[Tularemia]]||Microbiology||–||–
|-
| Infectious Diseases||[[Tularemia]]||Clinical manifestations||–||–
|-
| Infectious Diseases||[[Tularemia]]||Diagnosis & treatment||–||–
|-
| Infectious Diseases||[[Fever syndromes]]||Diagnosis approach||–||–
|-
| Infectious Diseases||[[Fever of unknown origin]]||Definition & etiologies||–||Etiologies of Classic FUO
|-
| Infectious Diseases||[[Fever of unknown origin]]||Workup||–||–
|-
| Infectious Diseases||[[Fever of unknown origin]]||Treatment||–||–
|-
| Infectious Diseases||[[Fever and rash]]||Approach to diagnostic workup||–||Possible Etiology
|-
| Infectious Diseases||[[Fever and rash]]||Treatment||–||–
|-
| Infectious Diseases||[[Fever in a returned traveler]]||Definition & etiologies||–||Common Etiologies of Fever in A Returned Traveler
|-
| Infectious Diseases||[[Fever in a returned traveler]]||Select clinical manifestations||–||–
|-
| Infectious Diseases||[[Fever in a returned traveler]]||Workup||–||–
|-
| Endocrinology||[[Hypopituitary syndromes]]||Panhypopituitarism||–||–
|-
| Endocrinology||[[Hyperpituitary syndromes]]||Pituitary tumors||–||–
|-
| Endocrinology||[[Hyperpituitary syndromes]]||Hyperprolactinemia||–||–
|-
| Endocrinology||[[Hyperpituitary syndromes]]||Acromegaly||–||–
|-
| Endocrinology||[[Hyperpituitary syndromes]]||Cushing's disease||–||–
|-
| Endocrinology||[[Hyperpituitary syndromes]]||Central hyperthyroidism||–||–
|-
| Endocrinology||[[Hyperpituitary syndromes]]||Multiple Endocrine Neoplasia Syndromes||–||Multiple Endocrine Neoplasia Syndromes
|-
| Endocrinology||[[Hyperpituitary syndromes]]||Polyglandular Autoimmune Syndromes||–||Polyglandular Autoimmune Syndromes
|-
| Endocrinology||[[Thyroid disorders]]||Diagnostic Studies in Thyroid Disorders||–||Diagnostic Studies in Thyroid Disorders
|-
| Endocrinology||[[Thyroid disorders]]||Approach to Thyroid Disorders||Approach to Thyroid Disorders||–
|-
| Endocrinology||[[Hypothyroidism]]||Etiologies||–||–
|-
| Endocrinology||[[Hypothyroidism]]||Hashimoto's thyroiditis||–||–
|-
| Endocrinology||[[Hypothyroidism]]||Clinical manifestations||–||–
|-
| Endocrinology||[[Hypothyroidism]]||Diagnostic studies||–||–
|-
| Endocrinology||[[Hypothyroidism]]||Treatment of overt hypothyroidism||–||–
|-
| Endocrinology||[[Hypothyroidism]]||Subclinical hypothyroidism||–||–
|-
| Endocrinology||[[Hyperthyroidism]]||Etiologies||–||–
|-
| Endocrinology||[[Hyperthyroidism]]||Clinical manifestations of hyperthyroidism||–||–
|-
| Endocrinology||[[Hyperthyroidism]]||Laboratory testing||–||–
|-
| Endocrinology||[[Hyperthyroidism]]||Graves' disease||–||–
|-
| Endocrinology||[[Hyperthyroidism]]||Thyroiditis||–||–
|-
| Endocrinology||[[Hyperthyroidism]]||Treatment||–||–
|-
| Endocrinology||[[Hyperthyroidism]]||Subclinical hyperthyroidism||–||–
|-
| Endocrinology||[[Nonthyroidal illness]]||Sick euthyroid syndrome||–||–
|-
| Endocrinology||[[Amiodarone and thyroid disease]]||Amiodarone-induced hypothyroidism||–||–
|-
| Endocrinology||[[Amiodarone and thyroid disease]]||Amiodarone-induced hyperthyroidism||–||–
|-
| Endocrinology||[[Thyroid nodules]]||Approach to thyroid nodules||Approach to thyroid nodules||–
|-
| Endocrinology||[[Cushing's syndrome]]||Definitions||–||–
|-
| Endocrinology||[[Cushing's syndrome]]||Etiologies of hypercortisolism||–||–
|-
| Endocrinology||[[Cushing's syndrome]]||Clinical manifestations||Approach to suspected Cushing's syndrome||–
|-
| Endocrinology||[[Cushing's syndrome]]||Treatment of Cushing's syndrome||–||–
|-
| Endocrinology||[[Hyperaldosteronism]]||Etiologies||–||–
|-
| Endocrinology||[[Hyperaldosteronism]]||Clinical manifestations||–||–
|-
| Endocrinology||[[Hyperaldosteronism]]||Diagnostic studies||Approach to suspected hyperaldosteronism||–
|-
| Endocrinology||[[Hyperaldosteronism]]||Treatment||–||–
|-
| Endocrinology||[[Adrenal insufficiency]]||Etiologies||–||–
|-
| Endocrinology||[[Adrenal insufficiency]]||Clinical manfiestations||–||–
|-
| Endocrinology||[[Adrenal insufficiency]]||Diagnostic studies||–||–
|-
| Endocrinology||[[Adrenal insufficiency]]||Adrenal insufficiency & critical illness||–||–
|-
| Endocrinology||[[Adrenal insufficiency]]||Treatment||–||–
|-
| Endocrinology||[[Pheochromocytoma]]||Clinical manifestations||–||–
|-
| Endocrinology||[[Pheochromocytoma]]||Diagnostic studies||–||–
|-
| Endocrinology||[[Pheochromocytoma]]||Treatment||–||–
|-
| Endocrinology||[[Adrenal incidentalomas]]||Epidemiology||–||–
|-
| Endocrinology||[[Adrenal incidentalomas]]||Differential diagnosis||–||–
|-
| Endocrinology||[[Adrenal incidentalomas]]||Workup||–||–
|-
| Endocrinology||[[Calcium disorders]]||Pitfalls in measuring calcium||–||Laboratory Findings in Calcium Disorders
|-
| Endocrinology||[[Hypercalcemia]]||Clinical manifestations||–||Etiologies of Hypercalcemia
|-
| Endocrinology||[[Hypercalcemia]]||Diagnostic studies||–||–
|-
| Endocrinology||[[Hypercalcemia]]||Treatment||–||Treatment of Hypercalcemia
|-
| Endocrinology||[[Hypercalcemia]]||Treatment of asymptomatic primary HPT||–||–
|-
| Endocrinology||[[Hypocalcemia]]||Clinical manifestations||–||Etiologies of Hypocalcemia
|-
| Endocrinology||[[Hypocalcemia]]||Diagnostic studies||–||–
|-
| Endocrinology||[[Hypocalcemia]]||Treatment||–||–
|-
| Endocrinology||[[Diabetes mellitus]]||Definition||–||–
|-
| Endocrinology||[[Diabetes mellitus]]||Categories||–||–
|-
| Endocrinology||[[Diabetes mellitus]]||Clinical manifestations||–||–
|-
| Endocrinology||[[Diabetes mellitus]]||Treatment||–||Diabetes Treatment Options
|-
| Endocrinology||[[Diabetes mellitus]]||Insulin Preparations||–||Insulin Preparations
|-
| Endocrinology||[[Diabetes mellitus]]||Complications||–||–
|-
| Endocrinology||[[Diabetes mellitus]]||Outpatient screening and treatment goals||–||–
|-
| Endocrinology||[[Diabetes mellitus]]||Management of hyperglycemia in inpatients||–||–
|-
| Endocrinology||[[Diabetic ketoacidosis]]||Precipitants||–||–
|-
| Endocrinology||[[Diabetic ketoacidosis]]||Pathophysiology||–||–
|-
| Endocrinology||[[Diabetic ketoacidosis]]||Clinical manifestations||–||–
|-
| Endocrinology||[[Diabetic ketoacidosis]]||Diagnostic studies||–||Typical DKA Flow Sheet Setup
|-
| Endocrinology||[[Diabetic ketoacidosis]]||Treatment||–||Treatment of DKA
|-
| Endocrinology||[[Hyperosmolar hyperglycemic state]]||Definition, precipitants, pathophysiology||–||–
|-
| Endocrinology||[[Hyperosmolar hyperglycemic state]]||Clinical manifestations & dx studies||–||–
|-
| Endocrinology||[[Hyperosmolar hyperglycemic state]]||Treatment||–||–
|-
| Endocrinology||[[Hypoglycemia]]||Clinical manifestations||–||–
|-
| Endocrinology||[[Hypoglycemia]]||Etiologies in diabetics||–||–
|-
| Endocrinology||[[Hypoglycemia]]||Etiologies in nondiabetics||–||–
|-
| Endocrinology||[[Hypoglycemia]]||Evaluation in nondiabetics||–||–
|-
| Endocrinology||[[Hypoglycemia]]||Treatment||–||–
|-
| Endocrinology||[[Lipid disorders]]||Measurements||–||–
|-
| Endocrinology||[[Lipid disorders]]||Primary dyslipidemia||–||–
|-
| Endocrinology||[[Lipid disorders]]||Secondary dyslipidemia||–||Secondary dyslipidemia
|-
| Endocrinology||[[Lipid disorders]]||Physical exam findings||–||–
|-
| Endocrinology||[[Lipid disorders]]||Treatment||–||NCEP Guidelines of Dyslipidemia
|-
| Endocrinology||[[Lipid disorders]]||Drug treatment||–||Drug Treatment of Dyslipidemia
|-
| Rheumatology||[[Arthritis]]||Approach to patients with joint pain||–||Key Physical Exam Findings in Joint Pain
|-
| Rheumatology||[[Arthritis]]||Approach to arthritis||Approach to arthritis||–
|-
| Rheumatology||[[Arthritis]]||Analysis of joint fluid||–||Analysis of Joint Fluid
|-
| Rheumatology||[[Arthritis]]||Comparison of major arthritides||–||Comparison of Major Arthritides
|-
| Rheumatology||[[Arthritis]]||Radiologic features||–||–
|-
| Rheumatology||[[Inflammatory markers & autoantibody testing]]||Inflammatory Markers||–||–
|-
| Rheumatology||[[Inflammatory markers & autoantibody testing]]||Autoantibody Testing||–||–
|-
| Rheumatology||[[Rheumatoid arthritis]]||Definition & epidemiology||–||–
|-
| Rheumatology||[[Rheumatoid arthritis]]||Clinical manifestations||–||Extra-Articular Manifestations of RA
|-
| Rheumatology||[[Rheumatoid arthritis]]||Laboratory & radiologic studies||–||–
|-
| Rheumatology||[[Rheumatoid arthritis]]||ACR/EULAR classification criteria of RA||–||ACR/EULAR classification criteria of RA
|-
| Rheumatology||[[Rheumatoid arthritis]]||Management||–||RA Therapeutics
|-
| Rheumatology||[[Adult onset still’s disease & relapsing polychondritis]]||Adult Onset Still’s Disease||–||–
|-
| Rheumatology||[[Adult onset still’s disease & relapsing polychondritis]]||Relapsing Polychondritis||–||–
|-
| Rheumatology||[[Gout]]||Definition & epidemiology||–||–
|-
| Rheumatology||[[Gout]]||Clinical manifestations||–||–
|-
| Rheumatology||[[Gout]]||Diagnostic studies||–||–
|-
| Rheumatology||[[Gout]]||Acute treatment||–||Acute Treatment of Gout
|-
| Rheumatology||[[Gout]]||Chronic treatment||–||Urate Lowering Therapy
|-
| Rheumatology||[[Calcium pyrophosphate dihydrate deposition disease]]||Definition||–||–
|-
| Rheumatology||[[Calcium pyrophosphate dihydrate deposition disease]]||Etiologies||–||–
|-
| Rheumatology||[[Calcium pyrophosphate dihydrate deposition disease]]||Clinical manifestations||–||–
|-
| Rheumatology||[[Calcium pyrophosphate dihydrate deposition disease]]||Diagnostic studies||–||–
|-
| Rheumatology||[[Calcium pyrophosphate dihydrate deposition disease]]||Treatment||–||–
|-
| Rheumatology||[[Seronegative spondyloarthritis]]||Classification system||–||–
|-
| Rheumatology||[[Seronegative spondyloarthritis]]||Epidemiology & pathogenesis||–||SpA Epidemiology and Features
|-
| Rheumatology||[[Seronegative spondyloarthritis]]||Major clinical manifestations||–||SpA Distinguishing Features
|-
| Rheumatology||[[Seronegative spondyloarthritis]]||Descriptions of skin manifestations||–||–
|-
| Rheumatology||[[Seronegative spondyloarthritis]]||Clinical assessment||–||–
|-
| Rheumatology||[[Seronegative spondyloarthritis]]||Treatment approach||–||–
|-
| Rheumatology||[[Infectious arthritis]]||Etiologies||–||–
|-
| Rheumatology||[[Infectious arthritis]]||Diagnosis||–||–
|-
| Rheumatology||[[Bacterial arthritis]]||Epidemiology & risk factors||–||–
|-
| Rheumatology||[[Bacterial arthritis]]||Clinical manifestations||–||–
|-
| Rheumatology||[[Bacterial arthritis]]||Additional diagnostic studies||–||–
|-
| Rheumatology||[[Bacterial arthritis]]||Treatment||–||Treatment of Bacterial Arthritis
|-
| Rheumatology||[[Bacterial arthritis]]||Prosthetic joint infections||–||–
|-
| Rheumatology||[[Disseminated gonococcal infection]]||Epidemiology||–||–
|-
| Rheumatology||[[Disseminated gonococcal infection]]||Clinical manifestations||–||–
|-
| Rheumatology||[[Disseminated gonococcal infection]]||Additional diagnostic studies||–||–
|-
| Rheumatology||[[Disseminated gonococcal infection]]||Treatment||–||–
|-
| Rheumatology||[[Olecranon and prepatellar bursitis]]||Epidemiology & risk factors||–||–
|-
| Rheumatology||[[Olecranon and prepatellar bursitis]]||Diagnosis||–||–
|-
| Rheumatology||[[Olecranon and prepatellar bursitis]]||Initial therapy||–||–
|-
| Rheumatology||[[Connective tissue diseases]]||Autoantibodies in Patients with Rheumatic Diseases||–||Autoantibodies in Patients with Rheumatic Diseases
|-
| Rheumatology||[[Systemic sclerosis and scleroderma]]||Definition & epidemiology||–||–
|-
| Rheumatology||[[Systemic sclerosis and scleroderma]]||Classification criteria||–||–
|-
| Rheumatology||[[Systemic sclerosis and scleroderma]]||Diagnostic studies & monitoring||–||Clinical Manifestations of Systemic Sclerosis
|-
| Rheumatology||[[Systemic sclerosis and scleroderma]]||Systemic Sclerosis Subgroup Comparison||–||SSc Subgroup Comparison
|-
| Rheumatology||[[Systemic sclerosis and scleroderma]]||Treatment||–||–
|-
| Rheumatology||[[Inflammatory myopathies]]||Definition & epidemiology||–||–
|-
| Rheumatology||[[Inflammatory myopathies]]||Clinical manifestations||–||–
|-
| Rheumatology||[[Inflammatory myopathies]]||Diagnostic studies||–||Differential Diagnosis of Myositides, Myopathies, and Myalgias
|-
| Rheumatology||[[Inflammatory myopathies]]||Treatment||–||–
|-
| Rheumatology||[[Sjogren's syndrome]]||Definition & epidemiology||–||–
|-
| Rheumatology||[[Sjogren's syndrome]]||Clinical manifestations||–||–
|-
| Rheumatology||[[Sjogren's syndrome]]||Diagnostic studies||–||–
|-
| Rheumatology||[[Sjogren's syndrome]]||Treatment||–||–
|-
| Rheumatology||[[Mixed connective tissue disease]]||Definition||–||–
|-
| Rheumatology||[[Mixed connective tissue disease]]||Clinical manifestations||–||–
|-
| Rheumatology||[[Mixed connective tissue disease]]||Diagnostic studies||–||–
|-
| Rheumatology||[[Mixed connective tissue disease]]||Treatment||–||–
|-
| Rheumatology||[[Raynaud's phenomenon]]||Clinical manifestations||–||–
|-
| Rheumatology||[[Raynaud's phenomenon]]||Primary Raynaud's phenomenon||–||–
|-
| Rheumatology||[[Raynaud's phenomenon]]||Secondary Raynaud's phenomenon||–||–
|-
| Rheumatology||[[Raynaud's phenomenon]]||Treatment||–||–
|-
| Rheumatology||[[Systemic lupus erythematosus]]||Epidemiology||–||Classification Criteria and Clinical Manifestations of SLE
|-
| Rheumatology||[[Systemic lupus erythematosus]]||Workup||–||Autoantibodies in SLE
|-
| Rheumatology||[[Systemic lupus erythematosus]]||Treatment||–||Treatment of SLE
|-
| Rheumatology||[[Systemic lupus erythematosus]]||Lupus nephritis||–||Lupus nephritis
|-
| Rheumatology||[[Systemic lupus erythematosus]]||Prognosis||–||–
|-
| Rheumatology||[[Systemic lupus erythematosus]]||Drug-induced lupus||–||–
|-
| Rheumatology||[[Vasculitis]]||Distinguishing Characteristics of Vasculitis Subtypes||–||Distinguishing Characteristics of Vasculitis Subtypes
|-
| Rheumatology||[[Large-vessel vasculitis]]||Takayasu's arteritis||–||–
|-
| Rheumatology||[[Large-vessel vasculitis]]||Giant cell arteritis||–||–
|-
| Rheumatology||[[Medium-vessel vasculitis]]||Polyarteritis nodosa||–||–
|-
| Rheumatology||[[Anca-associated small-vessel vasculitis]]||Differential Diagnosis of ANCA||–||Differential Diagnosis of ANCA
|-
| Rheumatology||[[Anca-associated small-vessel vasculitis]]||Granulomatosis with polyangiitis||–||–
|-
| Rheumatology||[[Anca-associated small-vessel vasculitis]]||Microscopic polyangiitis||–||–
|-
| Rheumatology||[[Anca-associated small-vessel vasculitis]]||Eosinophilic granulomatosis with polyangiitis||–||–
|-
| Rheumatology||[[Anca-associated small-vessel vasculitis]]||Renal-limited vasculitis||–||–
|-
| Rheumatology||[[Immune complex-associated small-vessel vasculitis]]||Henoch-Schonlein purpura||–||–
|-
| Rheumatology||[[Immune complex-associated small-vessel vasculitis]]||Cryoglobulinemic vasculitis||–||–
|-
| Rheumatology||[[Immune complex-associated small-vessel vasculitis]]||Connective tissue disease-associated vasculitis||–||–
|-
| Rheumatology||[[Immune complex-associated small-vessel vasculitis]]||Cutaneous leukocytoclastic angiitis||–||–
|-
| Rheumatology||[[Immune complex-associated small-vessel vasculitis]]||Behcet's syndrome||–||–
|-
| Rheumatology||[[Igg4-related disease]]||Definition & etiology||–||–
|-
| Rheumatology||[[Igg4-related disease]]||Clinical manifestations||–||–
|-
| Rheumatology||[[Igg4-related disease]]||Diagnosis||–||–
|-
| Rheumatology||[[Igg4-related disease]]||Treatment||–||–
|-
| Rheumatology||[[Cryoglobulinemia]]||Definition & types||–||–
|-
| Rheumatology||[[Cryoglobulinemia]]||Etiologies||–||–
|-
| Rheumatology||[[Cryoglobulinemia]]||Pathophysiology||–||–
|-
| Rheumatology||[[Cryoglobulinemia]]||Clinical manifestations||–||–
|-
| Rheumatology||[[Cryoglobulinemia]]||Diagnostic studies||–||–
|-
| Rheumatology||[[Cryoglobulinemia]]||Treatment||–||–
|-
| Rheumatology||[[Amyloidosis]]||Classification||–||Classification of Amyloidosis
|-
| Rheumatology||[[Amyloidosis]]||Clinical manifestations||–||Clinical Manifestations of Amyloidosis
|-
| Rheumatology||[[Amyloidosis]]||Diagnostic studies||–||–
|-
| Rheumatology||[[Amyloidosis]]||Treatment||–||–
|-
| Rheumatology||[[Amyloidosis]]||Prognosis||–||–
|-
| Neurology||[[Change in mental status]]||Definitions||–||–
|-
| Neurology||[[Change in mental status]]||Initial evaluation||–||Etiologies of Altered Mental Status
|-
| Neurology||[[Change in mental status]]||Neuro Exam of Altered Mental Status||–||Neuro Exam of Altered Mental Status
|-
| Neurology||[[Change in mental status]]||Glasgow Coma Scale||–||Glasgow Coma Scale
|-
| Neurology||[[Change in mental status]]||Initial treatment||–||–
|-
| Neurology||[[Change in mental status]]||Diagnostic studies||–||–
|-
| Neurology||[[Change in mental status]]||Further treatment of delirium||–||–
|-
| Neurology||[[Anoxic brain injury]]||Prevalence||–||–
|-
| Neurology||[[Anoxic brain injury]]||Initial evaluation||–||–
|-
| Neurology||[[Anoxic brain injury]]||Induced hypothermia||–||–
|-
| Neurology||[[Anoxic brain injury]]||Ongoing evaluation||–||–
|-
| Neurology||[[Anoxic brain injury]]||Prognosis||–||–
|-
| Neurology||[[Seizures]]||Definitions||–||–
|-
| Neurology||[[Seizures]]||Differential diagnosis||–||Seizure vs Syncope
|-
| Neurology||[[Seizures]]||Etiologies||–||–
|-
| Neurology||[[Seizures]]||Clinical manifestations||–||–
|-
| Neurology||[[Seizures]]||Clinical evaluation||–||–
|-
| Neurology||[[Seizures]]||Diagnostic studies||–||–
|-
| Neurology||[[Seizures]]||Treatment||–||Antiepileptic Drugs and Side Effects
|-
| Neurology||[[Seizures]]||Status epilepticus||–||Treatment of Status Epilepticus
|-
| Neurology||[[Alcohol withdrawal]]||Pathophysiology||–||–
|-
| Neurology||[[Alcohol withdrawal]]||Clinical manifestations||–||–
|-
| Neurology||[[Alcohol withdrawal]]||Clinical Institute Withdrawal Assessment scale for Alcohol||–||CIWA-Ar Scale
|-
| Neurology||[[Alcohol withdrawal]]||Treatment||–||–
|-
| Neurology||[[Ischemic stroke]]||Etiologies||–||–
|-
| Neurology||[[Ischemic stroke]]||Clinical manifestations||–||Stroke Syndromes by Vascular Territory
|-
| Neurology||[[Ischemic stroke]]||Transient ischemic attack||–||–
|-
| Neurology||[[Ischemic stroke]]||Physical exam||–||–
|-
| Neurology||[[Ischemic stroke]]||Acute workup||–||–
|-
| Neurology||[[Ischemic stroke]]||Workup to assess for etiology/modifiable risk factors||–||–
|-
| Neurology||[[Ischemic stroke]]||Acute treatment of ischemic stroke||–||–
|-
| Neurology||[[Ischemic stroke]]||Secondary stroke prevention||–||–
|-
| Neurology||[[Ischemic stroke]]||Patent foramen ovale||–||–
|-
| Neurology||[[Intracranial hemorrhage]]||Classification by location||–||–
|-
| Neurology||[[Intracranial hemorrhage]]||Etiologies||–||–
|-
| Neurology||[[Intracranial hemorrhage]]||Clinical manifestations||–||–
|-
| Neurology||[[Intracranial hemorrhage]]||Workup||–||–
|-
| Neurology||[[Intracranial hemorrhage]]||Management||–||–
|-
| Neurology||[[Weakness & neuromuscular dysfunction]]||Weakness & Neuromuscular Dysfunction||–||Weakness & Neuromuscular Dysfunction
|-
| Neurology||[[Peripheral neuropathies]]||Etiologies||–||–
|-
| Neurology||[[Peripheral neuropathies]]||Clinical manifestations||–||–
|-
| Neurology||[[Peripheral neuropathies]]||Diagnostic studies||–||–
|-
| Neurology||[[Peripheral neuropathies]]||Treatment of neuropathic pain||–||–
|-
| Neurology||[[Guillain-barre syndrome]]||Definition & epidemiology||–||–
|-
| Neurology||[[Guillain-barre syndrome]]||Clinical manifestations||–||–
|-
| Neurology||[[Guillain-barre syndrome]]||Diagnostic studies||–||–
|-
| Neurology||[[Guillain-barre syndrome]]||Treatment||–||–
|-
| Neurology||[[Myasthenia gravis]]||Definition & epidemiology||–||–
|-
| Neurology||[[Myasthenia gravis]]||Clinical manifestations||–||–
|-
| Neurology||[[Myasthenia gravis]]||Diagnostic studies||–||–
|-
| Neurology||[[Myasthenia gravis]]||Treatment||–||–
|-
| Neurology||[[Myopathies]]||Definition & epidemiology||–||–
|-
| Neurology||[[Myopathies]]||Clinical manifestations||–||–
|-
| Neurology||[[Myopathies]]||Diagnostic studies||–||–
|-
| Neurology||[[Headache]]||Primary headache syndromes||–||–
|-
| Neurology||[[Headache]]||Secondary causes of headache||–||–
|-
| Neurology||[[Headache]]||Clinical evaluation||–||–
|-
| Neurology||[[Migraine]]||Epidemiology||–||–
|-
| Neurology||[[Migraine]]||Definition & clinical manifestations||–||–
|-
| Neurology||[[Migraine]]||Treatment||–||–
|-
| Neurology||[[Back and spinal cord disease]]||Differential diagnosis of back pain||–||–
|-
| Neurology||[[Back and spinal cord disease]]||Initial evaluation||–||–
|-
| Neurology||[[Spinal cord compression]]||Clinical manifestations||–||–
|-
| Neurology||[[Spinal cord compression]]||Evaluation & treatment||–||Conus Medullaris vs Cauda Equina Syndromes
|-
| Neurology||[[Nerve root compression]]||Clinical manifestations||–||Cervical and Lumbar Radiculopathy
|-
| Neurology||[[Nerve root compression]]||Neurogenic vs Vascular Claudication||–||Neurogenic vs Vascular Claudication
|-
| Neurology||[[Nerve root compression]]||Treatment of nerve root compression||–||–
|-
| Surgical Issues||[[Abdominal pain]]||Viscera and Area to which pain referred||–||Viscera and Area to which pain referred
|-
| Surgical Issues||[[Abdominal pain]]||Etiologies of Abdominal Pain by Location||Etiologies of Abdominal Pain by Location||–
|-
| Surgical Issues||[[Abdominal pain]]||Inital evaluation||–||–
|-
| Surgical Issues||[[Acute abdomen]]||Definition||–||–
|-
| Surgical Issues||[[Acute abdomen]]||Etiologies||–||–
|-
| Surgical Issues||[[Acute abdomen]]||Inital evaluation||–||–
|-
| Surgical Issues||[[Acute abdomen]]||Initial management||–||–
|-
| Surgical Issues||[[Extremity emergencies]]||Acute limb ischemia||–||–
|-
| Surgical Issues||[[Extremity emergencies]]||Compartment syndrome||–||–
|-
| Surgical Issues||[[Surgical tubes, drains, and wounds]]||Tracheostomy||–||–
|-
| Surgical Issues||[[Surgical tubes, drains, and wounds]]||Chest tubes||–||–
|-
| Surgical Issues||[[Surgical tubes, drains, and wounds]]||Gastrostomy/jejunostomy tubes||–||–
|-
| Surgical Issues||[[Surgical tubes, drains, and wounds]]||Suture/staple removal||–||–
|-
| Ob/Gyn Issues||[[Vaginal bleeding]]||Etiologies||–||–
|-
| Ob/Gyn Issues||[[Vaginal bleeding]]||History & exam||–||–
|-
| Ob/Gyn Issues||[[Vaginal bleeding]]||Laboratory evaluation & imaging||–||–
|-
| Ob/Gyn Issues||[[Vaginal discharge]]||Etiologies||–||–
|-
| Ob/Gyn Issues||[[Vaginal discharge]]||Initial evaluation||–||–
|-
| Ob/Gyn Issues||[[Vaginal discharge]]||Treatment||–||–
|-
| Ob/Gyn Issues||[[Adnexal mass in non-pregnant woman]]||Etiologies||–||–
|-
| Ob/Gyn Issues||[[Adnexal mass in non-pregnant woman]]||Initial evaluation||–||–
|-
| Ophthalmic Issues||[[Acute visual changes]]||Etiologies of Acute Vision Loss||–||Etiologies of Acute Vision Loss
|-
| Ophthalmic Issues||[[Acute visual changes]]||Descriptions & etiologies of other visual changes||–||–
|-
| Ophthalmic Issues||[[Red eye]]||Common Etiologies of Red Eye||–||Common Etiologies of Red Eye
|-
| Ophthalmic Issues||[[Other conditions]]||Optic Nerve Disorders||–||–
|-
| Ophthalmic Issues||[[Other conditions]]||Ocular motor palsies||–||–
|-
| Ophthalmic Issues||[[Initial evaluation]]||Initial evaluation||–||–
|-
| ICU Medications||[[Icu medications]]||ICU Medications||–||ICU Medications
|-
| ACLS||[[Pulmonary edema, hypotension or shock]]||ACLS pulmonary edema, hypotension or shock algorithm||ACLS pulmonary edema, hypotension or shock algorithm||–
|-
| ACLS||[[Tachycardia]]||ACLS tachycardia algorithm||ACLS tachycardia algorithm||–
|-
| ACLS||[[Bradycardia]]||ACLS bradycardia algorithm||ACLS bradycardia algorithm||–
|-
| ACLS||[[Vf/pulseless vt, asystole, & pea]]||ACLS VF/Pulseless VT, asystole, & PEA algorithm||ACLS VF/Pulseless VT, asystole, & PEA algorithm||–
|-
| Quick References||[[Chest imaging patterns]]||Chest Imaging Patterns||–||Chest Imaging Patterns
|-
| Quick References||[[Peripheral smear findings]]||Peripheral Smear Findings||–||Peripheral Smear Findings
|-
| Quick References||[[Heparin for thromboembolism]]||Heparin for Thromboembolism||–||Heparin for Thromboembolism
|-
| Quick References||[[Heparin for acs]]||Heparin for ACS||–||Heparin for ACS
|-
| Quick References||[[Warfarin loading nomogram]]||Warfarin Loading Nomogram||–||Warfarin Loading Nomogram
|-
| Quick References||[[Warfarin-heparin overlap therapy]]||Warfarin-Heparin Overlap Therapy||–||Common Warfarin-Drug Interactions
|}

Revision as of 14:37, 10 November 2016

Retrieved from "https://www.wikidoc.org/index.php?title=Sandbox_coretopics&oldid=1268908"